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Gastrointestinal (GI) malignancies including esophagus and gastric cancer are 
diseases with high mortality rates. The patients suffering from GI cancers have poor 
survival rates mainly due to the advanced stages upon the initial time of diagnosis. 
Early diagnosis and localization of premalignant and malignant lesions together with 
appropriate curative treatment are therefore critical measures to reducing the mortality 
rates of the patients. The identification of precancer and early flat cancerous lesions 
can however be very challenging for clinicians using conventional endoscopy such as 
white light reflectance (WLR), narrowband imaging (NBI) and autofluorescence 
imaging (AFI). Current diagnostic gold standard relies on endoscopic biopsies that are 
invasive and a major burden to both the patient and society. 
 Raman spectroscopy is an inelastic light scattering technique with high 
molecular specificity. For tissue and cells, Raman spectroscopy is able to harvest a 
wealth of information from the myriad of inter- and/or intra- cellular components (i.e., 
proteins, lipids and deoxyribonucleic acid (DNA)). The main objective of this 
dissertation is to develop a fiber-optic Raman spectroscopy technique for real-time in 
vivo diagnosis of precancer and cancer in the upper GI during endoscopy.  
We develop a novel trimodal image-guided (i.e., WLR, NBI and AFI) fiber-
optic rapid Raman spectroscopy technique for real-time in vivo tissue Raman 
measurements at clinical endoscopic examinations. The novel Raman endoscopy 
technique enables high-quality in vivo Raman spectra to be measured within 0.5 s 
under the guidance of wide-field endoscopic imaging modalities (i.e., 
WLR/NBI/AFI). We utilize the novel Raman endoscopy technique for 
characterization of tissues belonging to different anatomical regions in the upper GI 
tract in vivo and explore the implications for early detection of neoplastic lesions. We 
XI 
show that the inter-anatomical variability of Raman spectra among normal gastric 
tissue (antrum, body, and cardia) is subtle compared to cancerous tissue 
transformation. In vivo Raman spectroscopy reveals the progressive changes of 
biochemical constituents in gastric tissue associated with preneoplastic and neoplastic 
transformation (i.e., intestinal metaplasia (IM), dysplasia and adenocarcinoma). 
Multi-class probabilistic partial least squares-discriminant analysis (PLS-DA) 
diagnostic algorithms based on in vivo Raman spectra are able to identify IM with 
sensitivity of 46.67% and specificity of 87.55%; dysplasia with sensitivity of 83.33%; 
specificity of 95.80%, and adenocarcinoma with sensitivity of 84.91% and specificity 
95.57%, respectively based on 1277 in vivo Raman spectra from 83 gastric patients. 
In order to realize prospective clinical diagnostics we develop an on-line 
diagnostic framework and demonstrate for the first time the prospective cancer 
diagnosis in 10 gastric patients at gastroscopy. Further, to significantly improve the 
sensitivity for epithelial precancerous lesions, a novel fiber-optic confocal Raman 
endoscopy technique is presented using a bevelled fiber-optic Raman probe coupled 
with a sapphire ball lens. We apply the online fiber-optic confocal Raman technique 
prospectively in 77 patients.  In vivo confocal Raman spectra show significantly 
spectral differences (p < 0.001) among different esophageal tissue types (i.e., 
columnar-lined epithelium, non-dysplastic BE and dysplastic BE). Fiber-optic 
confocal Raman spectroscopy provides a diagnostic sensitivity of 87.0% (67/77) and a 
specificity of 84.7% (610/720) for in vivo detection of dysplasia in 77 BE patients 
prospectively based on the endogenous biomolecular signatures.  
Finally we develop a second generation multiplexed Raman endoscopy 
technique using a single laser light together with a volume phase holographic (VPH) 
grating that simultaneously acquires both fingerprint (FP) and high wavenumber 
XII 
(HW) tissue Raman spectra in high resolution. We utilize a customized VPH dual-
transmission grating, which disperses the incident Raman scattered light vertically 
onto two separate segments (i.e., 150 to 1950 cm
-1
; 1750 to 3600 cm
-1
) of a charge-
coupled device camera (CCD). The rapid multiplexed Raman spectroscopy technique 
covering both FP and HW ranges developed has great potential for further improving 
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endoscopic acquisitions under WLR imaging guidance are also shown. .................. 106 
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Chapter 1. Introduction 
1.1 Background 
1.1.1 Gastric cancer 
Gastric cancers remain a serious disease and have one of the worst 5-year 
survival rates among malignancies. A total of 989,600 new stomach cancer cases and 
738,000 deaths are estimated to occur annually world-wide, accounting for 8% of the 
total cancer cases and 10% of total deaths.
1, 2
 In Singapore, gastric cancer is also a 
serious health burden. Gastric cancer is the fifth most common cancer in males and 
seventh most common cancer in females in Singapore.
3
 The age-standardized rate of 
gastric cancer is 21.4 per 100 000 per year in Chinese males and 10.8 per 100,000 per 
year in Chinese females.
3
 The epidemiology of gastric cancer is characteristic with 
significant demographic differences.
4
 The incidence is particularly high in East Asia, 
Eastern Europe, Russia and parts of Central and South America, and it is 
approximately twice as high among men than among women.
4
 In East-Asia (including 
China, Taiwan, Japan, Korea) and Russia the incidence of gastric cancer is much 
higher than other parts of the world. In multiracial countries such as Malaysia and 
Singapore, gastric cancer is more common in Chinese people than in those of Malay 
and Indian origin. The cause of gastric cancer is not fully understood but is likely 
linked with both genetic and environmental factors such as smoking, diet (smoked 
foods, salted fish and meat, and pickled vegetables) and Helicobacter Pylori (HP) 
infection.
5
 Infection by the bacterium HP is believed to be the primary cause of most 
intestinal-type stomach cancers while autoimmune atrophic gastritis, intestinal 
metaplasia (IM) and various genetic factors are associated with increased risk levels 
and is considered the part of the intestinal type carcinogenesis pathway.
6
 
Epidemiological data have shown that subjects who test positive for HP have at least 
2 
two-times increased risk of developing gastric cancer compared with those who test 
negative.
7
 HP eradication is therefore considered an important parameter to reduce the 




Gastric adenocarcinomas are the most common cancer type in the gastric and 
can be divided into two different subtypes (Lauren classification), that is: intestinal 
type gastric cancer and diffuse type gastric cancer. A higher incidence of intestinal 
type gastric cancer has been observed in males, blacks and older subjects, while the 
diffuse type gastric cancer has a similar incidence in both genders and is more 
frequent in younger individuals.
6, 9
 Intestinal type gastric carcinogenesis is widely 
accepted to be a multistep cascade of pathological events and has been described with 
the Correa model.
6
 The Correa pathway is depicted in Figure 1.1, which shows that 
the disease transformation occurs in sequential steps after exposure to HP, that is: 
chronic gastritis, atrophy, IM, dysplasia and ultimately neoplasia. The intestinal-type 
tumor is histopathologically characterized by irregular tubular structures, harboring 
pluristratification, multiple lumens, reduced stroma. Often, these tumors associate 
with severe IM in neighboring mucosa. 
 
Figure 1.1 Schematics of the Correa model of sequential mucosal changes in the development of 




Diffuse type gastric cancer on the other hand is considered more dependent on 
the genetic profile of the individuals.
10
 Unlike the complex disease pathway that 
characterizes intestinal-type carcinogenesis (Figure 1.1), diffuse gastric 
adenocarcinomas display prominent molecular abnormalities including defective 
intercellular adhesions. In most cases, this results from loss of expression of the cell 
adhesion protein E-cadherin.
11
 The tumor is histopathologically characterized by 
tumor cells that are discohesive and secrete mucus, which is delivered in the 
interstitium, producing large pools of mucus/colloid. The diffuse type cancers, are 
highly metastatic and characterized by more rapid disease progression than intestinal 
type gastric cancers.
12
  Partial or full gastric resections are commonly performed for 
these cancer types to reduce the risk of recurrence in the patients.  
 
1.1.2 Esophageal cancer 
Esophageal cancers can be divided into squamous cell carcinoma and 
esophageal adenocarcinoma. Both diseases have high mortality rates since the disease 
is often discovered late when the patient is symptomatic (e.g., dysphagia). This 
dissertation will mainly focus on Barrett‟s esophagus (BE) associated adenocarcinoma 
in the distal esophagus since this remains a major endoscopic challenge. BE is a 
complication of gastroesophageal (GE) reflux disease (GERD) and is a precursor of 
esophageal adenocarcinoma (EAC), which occurs above the proper gastroesophageal 
junction.
13
 Since the late 1970s, the BE disease has had a significant rise in incidence 
rates (>350%) in the developed countries.
13, 14
 Prevalences for BE ranging from 5 to 
25% have been reported, and approximately 5-15% of patients undergoing endoscopy 
for reflux symptoms have been found to be associated with BE.
15, 16
 BE is a 
4 
metaplastic precursor of EAC. There is some confusion in the literature regarding the 
exact definition of BE. In this dissertation we will follow American Gastrointestinal 
Association (AGA) recommendations with BE defined as the presence of goblet cells 
(i.e., IM phenotype) in the proper esophagus. Figure 1.2 shows the pathological 
transformation in BE. BE carcinogenesis is thought to develop from esophagitis, IM, 
dysplasia and ultimately cancer.
17
 The precise mechanisms through which reflux 
constituents drive the carcinogenic process in the esophagus are however poorly 
understood. GERD might act individually or together at many points in the disease 
pathway, from the development of BE through to progression from dysplasia to 
EAC.
18





Figure 1.2 The Barrett's esophagus (BE) carcinogenesis sequence associated with 
gastroesophageal reflux disease (GERD).  
 
 
1.1.3 Conventional cancer screening methods 
Flexible endoscopy in patients with suspicious symptoms in the upper GI is the 
primary choice for the clinician. Current standard flexible endoscopic diagnostics in 
the esophagus and gastric are based on conventional white-light reflectance (WLR) 
endoscopic imaging. In recent years, optical imaging methods, such as the narrow-
5 
band imaging (NBI) technique, which enhances visualization of irregular mucosal and 
vascular patterns, has shown promising diagnostic potential for in vivo detection of 
precancer and early cancer at endoscopy.
19
 While NBI imaging techniques provide 
higher detection sensitivities, this wide-field endoscopic imaging modality still suffer 
from moderate diagnostic specificities due to inter-observer dependence and the 
inherent lack of ability to reveal endogenous biochemical information about the 
tissue.
20
 Very recently, autofluorescence imaging (AFI) has emerged as a diagnostic 
tool.
21
 AFI reveals biochemical information by imaging the endogenous fluorephores 
in the tissue but this technique has not yet gained widespread acceptance. Endoscopic 
biopsies of suspicious lesions that are sent for histopathological examination remain 
the current gold standard in the upper GI.   
 
1.1.4 Motivation and research objectives 
Early identification and intervention are the most critical measures to reducing 
the cancer-related mortality rates in the GI tract.
8
 Dysplastic lesions or grossly 
inconspicuous cancers are however endoscopically indistinguishable from the 
surrounding benign tissue using conventional WLR/NBI/AFI endoscopy. Subtle 
changes of early lesions (e.g., dysplasia, carcinoma in situ (CIS)) may not be 
apparent, limiting the diagnostic sensitivity. This is because conventional endoscopic 
modalities heavily rely on visual assessment of structural and morphological details 
and provide little or no biomolecular information. Endoscopic inspections are 
therefore associated with a vast number of unnecessary biopsies, which are clinically 
labour intensive and also a burden to the patients and society. On top of this, 
histopathological characterization of minute specimens can also be highly subjective. 
For instance, inter-observer disagreements of up to >50% have been reported for low-
6 
grade dysplasia (LGD) in BE.
22, 23
 The identification of surgical margins remains 
another great challenge in clinical endoscopy. Achieving negative resection margins, 
defined as the absence of dysplasia or cancer, provides lower associated rates of local 
recurrence. Residual lesions after resection however frequently occur.
24
 In clinical 
practice, as many as 20-30% of patients undergoing endoscopic mucosal resection 
(EMR) require a second surgical procedure due to local recurrence indicative of 
incomplete cancer resection that were missed on margin assessment.
24
 Thus, it is of 
imperative clinical value to develop non-invasive and sensitive optical diagnostic 
technologies that can assist in guiding endoscopists for the targeted biopsies of 
suspicious lesions (i.e., precancer and cancer), and for surgery and management of GI 
patients.
3
 The development of a rapid and non-invasive or minimally invasive optical 
point-wise diagnostic technique enabling the direct assessment of specific 
biochemical and biomolecular information about suspicious lesions in vivo to 
complement the WLR/AFI/NBI imaging would represent a significant advance in the 
early diagnosis and management of upper GI malignancies. Reflectance spectroscopy, 
fluorescence and Raman spectroscopy have become promising candidates for in vivo 
diagnostics in medicine. Among these optical spectroscopic techniques, Raman 
spectroscopy is the most biomolecular-specific but also the one that is most 
technically difficult to realize in practice. Raman spectroscopy is an inelastic light 
scattering technique that is capable of probing the highly specific vibrational 
frequencies of biomolecules.
25
 For tissues and cells, Raman spectroscopy enlightens 
the surface and subsurface cellular structures and conformations. Accumulating 
evidence has confirmed the capability of Raman spectroscopy to detect precancer and 
cancerous lesions ex vivo for different tissue types and organs.
26-31
  For instance, the 
diagnostic sensitivities and specificities in the range of 85–95% and 90–98% have 
7 
been reported for differentiation between different pathologic types (e.g., IM, 
dysplasia and adenocarcinoma) of gastric tissue using NIR Raman spectroscopy 
associated with multivariate analysis.
26-30
 Recently the first commercial Raman device 
has been developed (Aura, Verisante Inc). To date there however does not exist 
Raman techniques that routinely can be applied in the gastrointestinal tract. 
  
1.2 Specific aims and organization  
The main objective of this dissertation is to develop a real-time fiber-optic Raman 
spectroscopy technique for early diagnosis of precancer and cancer in the upper GI 
tract in vivo. The specific aims are formulated as follows: 
1. To develop a real-time fiber-optic Raman spectroscopy technique for the 
upper GI tract and characterize/explore inter-anatomical Raman spectral 
variability of normal tissue in the esophagus and gastric and compare with that 
of cancerous transformation in vivo (Chapter 4). 
2. To explore the diagnostic utility of fiber-optic Raman spectroscopy for 
elucidation of gastric intestinal type carcinogenesis and diagnosis of different 
precancerous and cancerous lesions in vivo at endoscopy (Chapter 5). 
3. To develop an on-line fiber-optic Raman spectroscopic framework in order to 
realize real-time prospective in vivo tissue diagnosis during clinical endoscopy 
(Chapter 6). 
4. To improve the sensitivity to epithelial lesions by developing a novel fiber-
optic confocal Raman spectroscopy technique and demonstrate the prospective 
on-line in vivo tissue diagnosis of precancer in Barrett‟s esophagus (Chapter 
7). 
8 
5. To develop a second-generation real-time Raman endoscopy technique that 
acquires both the fingerprint (FP) and high-wavenumber (HW) Raman signals 
simultaneously in high resolution for improving tissue characterization and 
diagnosis (Chapter 8). 
 
Chapter 9 gives a discussion on the study limitations and scope of potential clinical 
applications of the fiber-optic Raman endoscope technique. Finally the thesis is 
concluded and future directions are given for further exploration of fiber-optic Raman 
spectroscopy in GI precancer and cancer detection and diagnosis. 
9 
 
Chapter 2. Overview of endoscopic imaging and 
spectroscopy techniques  
2.1 Conventional endoscopic imaging  
Flexible WLR endoscopy remains the current standard tool for diagnostics and 
is based on the reflection of visible broadband light from a xenon lamp (Figure 2.1). 
The diagnostic accuracy for identification of precancer and early flat cancer is 
however very limited. In one study based on 43 patients the sensitivity, specificity, 
positive and negative predictive values for detection of gastric premalignant lesions 
were 51, 67, 62 and 55% for WLR.
20
 This is due to the fact that WLR only reveals 
gross morphological changes with no specific biochemical information about the 
tissue. WLR endoscopy is in general subjective and heavily depends on the 
experience of the endoscopist. Recently, NBI modality has emerged as a novel 
technique that enhances microvascular patterns (Figure 2.1).
19
 NBI uses two discrete 
bands of light: One blue e.g., at 415 nm and one green at e.g., 540 nm. Since tissue 
have different absorption properties at the two wavelengths, narrowband blue light 
displays superficial capillary networks, while green light displays sub-epithelial 
vessels and when combined offer a high-contrast image of the tissue surface. 
Specificity, sensitivity, positive and negative predictive values for detection of 
premalignant lesions of 71, 58, 65 and 65% for NBI and 51, 67, 62 and 55% for WLE, 
have been reported respectively.
20
 NBI improves the specificity compared to WLR but 
still remains in low end ~70%.
20
  
Despite developments of zoom endoscopy and high-resolution/high-definition 
imaging, both WLR and NBI remain suboptimal for accurate in vivo detection of 
10 
precancers due to lack of revealing the cellular biochemical/biomolecular information. 
For this reason, AFI modality has been developed (Figure 2.1). AFI reveals more 
biochemical information through imaging of the endogenous fluorephores in the 
tissue. In endoscopic AFI mode, a rotating color filter wheel in front of the xenon 
light source sequentially generates blue light (390-470 nm) and green light (540-560 
nm) for tissue illumination. A filter situated in front of the AFI CCD blocks the blue 
light excitation but enables tissue autofluorescence (500-630 nm) and reflected green 
light to filter through. The sequentially captured images of autofluorescence and green 
reflectance are integrated by the video processor into a real-time pseudocolor image in 
which normal mucosa appears green, and dysplastic and neoplastic tissue appears 
dark purple (Figure 2.1).  
 
Figure 2.1 White light reflectance (WLR), narrowband imaging (NBI) and autofluorescence 
imaging (AFI). The images were obtained from Endoscopy Center with permission, National 
University Hospital of Singapore (NUHS). 
 
The diagnostic utility of AFI technology however still remains debatable. One study 
compared WLR with AFI for experienced and inexperienced endoscopists.
21
 The 
sensitivity, specificity, and accuracy were reported as 70%, 78%, and 75%, 
respectively, for AFI and 81%, 76%, and 78%, respectively, for WLE in the 
experienced group. In the less experienced group, sensitivity, specificity and accuracy 
were 80%, 81% and 80%, respectively, for AFI and 65%, 77%, and 72%, respectively, 
for WLE.
21
 Very recently the clinical value of trimodal endoscopic imaging (i.e., 
11 
WLR/NBI/AFI) has been investigated.
32
 Results have indicated that AFI/NBI 
identified significantly more patients with IM than WLR alone.
32
 In general, much 
research has been conducted in endoscopic imaging modalities, but recent directions 
have been guided more toward molecular imaging. Techniques such as near-infrared 
(NIR) labeled fluorescence markers (i.e., antibodies or peptides) and nanoparticles 
with integrated drug delivery capability are currently being investigated.
33
 Since these 
technologies rely on exogenous agents and compounds, the translation into clinical 
medicine is more challenging. 
 
2.2 Advanced endoscopic techniques 
Confocal laser endomicroscopy 
Confocal laser endomicroscopy (CLE) is a recently developed microscopic 
imaging modality with small field of view (FOV) for endoscopic applications.
34
 There 
are two types of CLE: endoscope-based CLE (eCLE), which is integrated in the distal 
tip of the endoscope, and probe-based CLE (pCLE), a fiber-optic technique using the 
accessory channel of the endoscope. This technique uses intravenous agents (i.e., 
fluorescein) for improving the tissue contrast. CLE magnifies the tissue surface using 
a distal optical system for visualization of cellular structures (i.e., crypts, 
microvasculature etc.). Clinical data of CLE have been reported in GI diseases 
including BE, gastric, and colon.
34, 35
 Promising results have been reported for 
detection of precancer and cancer.
71, 97
 Figure 2.2 displays the in vivo confocal 
endomicroscopic image acquired at Endoscopy Center, National University Hospital 
of Singapore (NUHS), showing apparent presence of intestinal-type goblet cells 
(black spots) in BE. Although promising results have been reported, the accuracy and 
12 
clinical merit of this modality still remains debatable as indicated in a large 
randomized multicenter trial.
35
 This technique needs expert training and is still 
associated with subjective interpretations. 
 
Figure 2.2 Confocal laser endomicroscopic images acquired from (a) normal and (b) Barrett‟s 
esophagus at Endoscopy Center, National University Hospital, Singapore (NUHS). (Pentax inc. 
Japan). 
 
Optical coherence tomography 
Optical coherence tomography (OCT) is another technique for morphological 
and architectural cross sectional imaging based on interferometry.
36
 OCT obtains 
cellular images of epithelial and sub-epithelial tissue with a definition of 1 – 10 mm37. 
High levels of diagnostic accuracies have been reported (80%) for differentiating 
between dysplasia and adenocarcinoma.
38
 Despite encouraging results, the technique 
has not found its way into routine clinical endoscopy. Like CLE, this technique relies 
on subjective interpretations of gross architectural features of mucosa. This cross 
sectional technique could have potential use staging of precancer and cancers (i.e., 
assessment of tumor invasion). More exotic OCT techniques include angle-resolved 




Point-wise endogenous spectroscopic techniques 
Optical spectroscopic techniques such as elastic light scattering spectroscopy 
(ESS), fluorescence and Raman spectroscopy have been comprehensively 
investigated for the evaluation of malignancies in tissues.
40-46
 ESS reveals changes in 
13 
the physical properties of cells (i.e., nuclear size, shape and density and general 
morphology).
47
 In 2006 Lovat and colleagues published a study showing high 
sensitivity of 92% however with low specificity of 60% for diagnosis in BE.
47
 The 
technique has recently been extended to a rotational scanning device for the distal 
esophagus for Barrett‟s disease.48 The clinical merit and diagnostic yield of this 
technique have not been reported to date and the technique has therefore not gained 
widespread acceptance yet.  
Fluorescence spectroscopy is another point-wise technique but with higher 
biochemical specificity than ESS.
49
 Fluorescence spectroscopy probes tissue 
composition by exciting biomolecules to an electronic eigenstate followed by 
relaxation to the electronic ground state. Fluorescence spectroscopy typically uses 
violet-blue excitation.
50
 It‟s widely accepted that this technique probes fluorophores 
such as NADH, collagen, elastin, tryptophan etc. that undergo quantitative changes 
during tissue carcinogenesis.
50
 Recently the use of NIR-excited autofluorescence has 




Raman spectroscopy is the most molecular specific technique for endogenous 
tissue compositional analysis
26-31
 but also the technique that is most challenging to 
realize in clinic settings.
54
 In vivo Raman clinical endoscopic applications are 
extremely challenging and have been limited not only by the difficulty in capturing 
inherently weak tissue Raman signals, but also by the slow speed of spectral 
measurements (>5 sec). The miniaturization of flexible fiber-optic Raman probes that 
can pass down the accessory channel of medical endoscopes for effective tissue 
Raman light collections presents another great challenge in clinical Raman 
spectroscopy. To overcome the weak signals, more exotic techniques such as surface 
14 
enhanced Raman spectroscopy (SERS) are being explored ex vivo.
55
 Since 
conventional NIR Raman spectroscopy is the main topic of this dissertation, the 
following sections introduces the more comprehensive physical and instrumental 
foundations of the Raman scattering effect as well as literature studies. 
 
2.3 Raman spectroscopy 
2.3.1 The Raman scattering effect 
Raman spectroscopy is a non-destructive inelastic light scattering technique 
capable of probing vibrational modes of molecules without labeling. In 1928, the 
Indian physicist Sir Chandrasekhara Venkata Raman (1888-1970) discovered the 
Raman effect, and won the 1930 Nobel Prize in Physics “as the first Asian for his 
work on the scattering of light and for the discovery of the effect named after him”.56 
When photons interact with a molecule, energy can be exchanged either through 
absorption or elastic/inelastic scattering. For an absorption process to happen, a 
change in net dipole must occur. In contrast, a net polarization change of the molecule 
is required for inelastic scattering to occur. The induced dipole moment P is 
proportional to the electric field of the incident wave E and the polarizability.  
                                                    P E      [1] 
 
Expanding this and using harmonic vibrations i.e., 3N-6 normal vibrations (or 3N-5 
for linear molecules), one obtains  
       0 0 0 0 0 0 0 0
1
cos2 ( / ) [cos{2 ( ) } cos{2 ( ) }]
2
m mP E v t q q E v v t v v t            [2] 
 
Where α0 is the polarizability of the molecule, E0 and v0 are the vibrational amplitude 
and frequency of incident light, q0 and vm are the vibrational amplitude and frequency 
15 
of the molecule, respectively. The first term is named Rayleigh scattering, which 
occurs at the same frequency as the incident light, and has a magnitude proportional 
to α0, the inherent polarizability of the molecule. The second term is anti-Stokes 
Raman scattering, which occurs at v0+vm and the third term is Stokes Raman 





Figure 2.3 Energy transition diagram showing (a) Stokes and (b) anti-Stokes Raman scattering. 
 
 
Figure 2.3 depicts the Jablonski diagram of conventional Raman scattering. Briefly, 
the incident photon excites the molecule to a short living virtual energy state. If the 
energy of the incident photon is unchanged after interaction with the molecule, 
Rayleigh scattering (i.e., elastic scattering) occurs. However, depending on the 
specific vibrational mode and molecular configuration a very small proportion of 
incident photons (~1 in 10
8
) can be scattered with a change in frequency (i.e., Raman 
scattering). The absolute Raman scattering cross-section of molecules depends on the 
polarizability change associated with a vibrational mode. The simple classical 
description above (or semi-classical descriptions) however does not explain absolute 
intensities and why certain selection rules occurs as observed in experimental Raman 
spectroscopic data.
58
 Hence, a rigorous description based entirely on quantum 
mechanics is necessary to fully appreciate experimental Raman data.
58
 Kramer-
Heisenberg dispersion (KHD) relation is the fundamental equation in scattering theory 
and can be derived analytically through time-dependent perturbation theory of the 
16 
interaction between a quantized electronic system (i.e., the molecular Hamiltonian) 
and the second quantized photon field (i.e., field Hamiltonian).
59
 Briefly, the energy 
states of any molecule can be resolved into internally coupled electronic, vibrational 
and rotational energies. In adiabatic formalism (i.e., Born Oppenheimer 
approximation), the electronic state can be separated from the vibrational and 
rotational states.
59
 The second quantization of the photon field (i.e., field Hamiltonian) 
can be represented by an infinite number of harmonic field oscillators with different 
frequencies.
59
 The transition probability amplitude of Raman scattering can be 
determined using time dependent perturbation theory.
59
 A rigorous derivation of KHD 
equation from first principles can be found elsewhere.
58, 59
 Equation [3] shows the 
typical form of the KHD equation (i.e., differential scattering cross section) used in 
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Where a is the initial state of the molecule, b is the final state of the molecule, r is the 
virtual state, ωk is the angular frequency for the incoming photons, ωk’ is the angular 
frequency for the scattered photons. Ea, Eb and Er are the energies of initial, final and 
virtual states respectively. γ is a dampening of the virtual state and ku and 
*
'ku  are the 
polarization vectors for the incoming and scattered photon, ˆer is the electrical dipole 
operator. In brief, the Raman differential scattering cross-section is here given as the 
square of a coherent superposition of all molecular eigenstates. Therefore Raman 
scattering is quantum mechanically considered a “coherent absorption-emission” 
process. This equation is complex as the square of cross-terms appears. Important 
experimental effects can be derived from the equation: (i) in principle, all eigenstates 
of the molecule contributes in a coherent manner to the scattering process (ii) when 
17 
the incident light is in resonance with an electronic state, the scattering cross section 
is enhanced (i.e., resonance Raman effect). (iii) The Raman scattering cross section is 
inversely proportional to the fourth power of laser wavelength. The above quantum 
mechanical descriptions of the Raman scattering process allow one to rightly 
appreciate the high molecular specificity of the Raman scattering effect. 
2.3.2 Raman instrumentation for tissue measurements  
Raman spectroscopy requires monochromatic light to produce a well resolved 
spectrum.
60
 Lasers produce a coherent beam of monochromatic light and are therefore 
used as an excitation source. For bulk structural investigations, visible excitation is 
typically utilized (e.g., Ar+ ion - 488 and 514.5 nm, Kr+ ion - 530.9 and 647.1 nm, 
He-Ne laser - 632.8 nm) for conventional Raman spectroscopy or resonance Raman 
spectroscopy.  For biological application, NIR excitation is most commonly used (i.e., 
785, 830 or 1064 nm). This is mainly due to the low light absorption of tissue in this 
spectral range (i.e., deeper tissue penetration due the tissue-optical window) as well as 
prominent reduction in interfering autofluorescence compared with visible 
excitation.
57
 Nowadays, compact electronically controlled wavelength stabilized and 
narrow line-width NIR diode lasers have replaced the gas and neodymium-doped 
yttrium aluminum garnet (Nd:YAG) lasers because of their low cost, compact sizes 
and reliability.
60
 The development of high-throughput imaging spectrographs based 
either on volume phase holographic (VPH) transmission or reflective type gold coated 
gratings with high efficiency has recently paved for rapid Raman spectroscopy 
techniques in medicine.
57
 High-throughput imaging spectrographs with low f/# 
(e.g., f/1.8 or f/2.2), low stray light background (10
-11
), NIR optimized optics are now 
being produced by several manufactures. Spectral range coverage varies according to 




wavenumber (HW) region (2800 - 4000 cm
-1
) or both). The spectrometer resolution is 
determined by several complex factors (including grating, entrance slit width and 
CCD pixel size).
57
 CCD detection systems have generally replaced the single-channel 
detector (e.g., photomultiplier tubes (PMT) etc.). CCD‟s are most commonly 
characterized by the detection sensitivity (i.e., quantum efficiency (QE) at a certain 
temperature) and dark current rate.
61, 62
 To reduce dark current, thermoelectric or 
cryogenic cooling of the CCD is commonly used. Since development of miniaturized 
fiber-optic probes for endoscopic sampling remains one of the major challenges in 
medicine, the following section will discuss fiber-optic Raman probes for endoscopic 
applications in more details.   
 
2.3.3 Fiber-optic Raman probes for endoscopy 
The difficulty in developing miniaturized flexible fiber-optic Raman probe 
designs with high collection efficiencies that are accessible in endoscopic applications 
have hindered the routine use of Raman spectroscopy in clinical settings.
63, 64
 
Comprehensive reviews of fiber-optic probes for biomedical spectroscopy can be 
found by Utzinger et al and Krafft et al.
63, 65
 There are several important design 
considerations for fiber-optic Raman probes in endoscopic applications:
66-68
 
(i) The probe must have high collection efficiency to be able to acquire Raman spectra 
in very short acquisition time (<1-0.5 sec). (ii) Integration of distal band pass and long 
pass filters is common to reduce laser noise, Rayleigh scattered light as well as fused-
silica Raman and fluorescence interference. (iii) There are strict geometry 
considerations for clinical use to fit into the instrument channel of endoscopes (e.g., 
endoscope, bronchoscope, colonoscope etc.). For instance, in gastroscopes, the 
instrument channel is ~2.2 mm (iv) The fiber-optic probe must be flexible, bio-
19 
compatible and able to withstand medical sterilization. Zhang et al. were one of the 
first to test different designs of endoscopic-type fiber-optic probes (single fiber, 
simple bifurcated probe and bifurcated probe with narrow band coating at the 
excitation fiber tip) on chicken fat tissue.
67
 The bifurcated volume-type fiber bundle 
with separate illumination and collection fibers were proposed to reduce the intrinsic 
fiber Raman and fluorescence signal. Zhang et al. found that the miniaturized 
bifurcated multi-fiber probe with filters in front of the excitation fiber and collection 
fibers could reduce the interference of fiber silica fluorescence and Raman signals.
67
  
Since carcinogenesis typically initiates in the epithelial layer it has been 
realized that controlling the probing depth and sampling volume is clinically very 
important. Several design strategies such as beveled collection fibers, have been 
proposed to maximize shallower tissue Raman measurements in the epithelial tissue. 
In 1999, Wilson et al. developed a beveled endoscopic fiber probe
69
 and performed 
the pioneering work on in vivo Raman endoscopic spectral measurements from the GI 
tract.
70
 Wilson et al. used a 1.5 m long endoscopic compatible probe that consisted of 
a single 400 µm diameter central delivery fiber, surrounded by seven 300 µm 
diameter beveled collection fibers in order to realize high collection efficiency. 
Wilson and co-workers utilized the probe in vivo and successfully detected dysplastic 
lesions in BE.
71
 Apart from the beveled collection fibers, the use of gradient index 
(GRIN) lenses and ball lens-coupled Raman probes have also been proposed as 
alternative methods to improve depth selectivity and collection efficiency.  In 2004, 
Motz et al. presented a 2 mm diameter sapphire ball lens coupled fiber-optic probe
66
 
equipped with a rod filter module. The distal ball lens was utilized to improve the 
performance and collection efficiency of the probe. The diagnostic utility of the probe 
was tested through simulations, tissue model experiments and ex vivo tissues such as 
20 
artery and breast tissue samples.
66
 Short et al. developed an endoscopic fiber-optic 
catheter Raman probe featuring a 200 µm central excitation fiber with the surrounding 
27 collection fibers (100 µm diameter each) to characterize lung tissue in vivo.
72
 Day 
et al. have very recently designed a miniaturized confocal endoscopic Raman probe 
consisting of a single illumination fiber and a single collection fiber utilizing a GRIN 
lens for optimizing the depth of focus ~150 µm to study early esophageal 
carcinogenesis.
68
 Krafft and colleagues reported on the miniaturized (~0.375 mm 
diameter) fiber-optic probe based on multi-core single-mode fibers (MCSMF) with 
inscribed in-line fiber Bragg grating (FBG).
73
 The applicability of the developed 
probe for clinically relevant samples was tested on porcine brain tissue.  
In general, the laser excitation power density on tissue should be kept within a 
range that does not generate cytotoxity in cells. At the time of writing there exist no 
guidelines or standards on the use of NIR lasers (e.g., 785 nm) in internal epithelial 
organs. For this reason, as a general guideline, one should not apply more than a 
maximum 1.5 W/cm2 on the tissue sample which is the maximum permissible skin 







2.4 Multivariate analysis for tissue spectroscopic diagnosis 
2.4.1 Spectral preprocessing 
Since tissue Raman spectra are complex and represent a superposition of 
autofluorescence and weak Raman signals from a myriad of biomolecules it is 
important to apply sophisticated signal processing to standardize the Raman signal 
21 
prior to analysis. Preprocessing techniques serve to eliminate redundant spectral 
variation or noise in the raw Raman spectra. A multitude of preprocessing techniques 
exists that can be applied to datasets of Raman spectra such as noise removal 
techniques (e.g., Fourier filtering, median filtering, Savitzky-Golay filtering etc.), 
normalization (e.g., peak or area normalization, multiple scatter correction (MSC), 
extended multiple scatter correction (EMSC)).
75, 76
 In particular, the developments of 
robust autofluorescence baseline removal techniques remain important in Raman 
spectroscopy.
64, 77
 Tissue autofluorescence signals are typically many orders in 
magnitude more intense that the Raman peaks.
78
 Removal of autofluorescence can be 
realized using different methodologies such as wavelet transformation,
79
 shifted 




 Fourier transform, etc. 
Many research groups have realized that 4-6
th
 order polynomial constrained to the 
lower portion of the calibrated spectra is a robust methodology to efficiently remove 





 To demonstrate this, Figure 2.4 shows the 5
th
 order fitting of the 
autofluorescence signal from GI tissue in vivo. The Raman spectrum is also shown 
after autofluorescence subtraction revealing the distinct Raman peaks with essentially 
no slope or baseline offset. Notice that although it is common to subtract/remove the 
tissue autofluorescence in the literature,
26-31
 autofluorescence carries molecular 
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Figure 2.4 Autofluorescence background and Raman signal from gastric tissue. Raman signal 
after autofluorescence 5
th
 order polynomial background subtraction iteratively constrained to the 
lower portion of the spectra. 
 
2.4.2 Principal component analysis (PCA) 
Empirical approaches to analyze Raman spectra (e.g., intensity peaks or 
intensity ratio of Raman peaks) have been used to classify Raman spectra according 
to tissue pathology types.
27
 Simple intensity ratio algorithms provide tissue 
information which is independent of Raman spectroscopic measurement conditions 
(e.g., absolute intensities).
26
 Multivariate/chemometric analysis is however needed to 
extract biomolecular information for clinical diagnostics. Principal component 
analysis (PCA) has become a standard technique for multivariate/chemometric 
analysis of optical spectroscopic data.
81
 Briefly, this mathematical technique reduces 
the dimension of the entire Raman spectrum to a reduced number of data points by 
finding eigenvectors and eigenvalues to the covariance matrix of the dataset.
82
 That is, 
23 
extracting the largest spectral variations successively. Accordingly, PCA decomposes 
the spectra into loading and scores (i.e., principal components (PCs)), in matrix 
notation: 
                                                   
TX=TP +E                 [4] 
where T and P represent scores and loadings, and E contains the residuals. For 
instance, loading one (i.e., the first vector in P) represents the largest spectral 
variation in the data and the score value is the projection of the spectrum on the 
loading. This applies successively for each PC. In other words, the loadings 
correspond to a new rotated coordinate system, and scores represent the data 
projection values. Choosing the number of PCs for diagnostic purposes remains 
tentative and must be based on common sense to avoid overfitting the data. Most 
literature studies use analysis of variance (ANOVA) and p-values among different 
groups to choose the PCs.
28
 PCA can be combined with clustering or linear/non-linear 
discriminant analysis for classification.
81
 The PCA scores can in principle be fed to 
any clustering analysis (e.g., K-nearest neighbours, etc.). Other useful classification 
techniques include for instance support vector machines (SVM), which maps the 
spectra into a higher dimensional space through either a linear or nonlinear kernel,
83
 
or classification and regression trees (CART) as well as swarm intelligence or genetic 




2.4.3 Partial least squares discriminant analysis (PLS-
DA) 
Partial least squares (PLS) is a powerful regression method for spectral data. 
PLS can also advantageously be applied for discriminant analysis (DA) problems by 
encoding the class membership of zeros and ones, representing group affinities in an 
24 
appropriate Y-indicator matrix. PLS-DA employs the fundamental principle of PCA 
but further rotates the coordinate system (i.e., latent variables (LVs)) by maximizing 
the covariance between the spectral variation and group affinity so that the LVs 
explain the diagnostic relevant variations rather than the most prominent variations in 
the spectral dataset.
90
 The general model is given in matrix notation as equation [5] 
                       
T
T
X = TP +E
Y = UQ +F
                            [5]    
where T and P represent scores and loadings for the spectral data, and E contains the 
residuals. U and Q represent scores and loadings for the affinity matrix, and F 
contains the residuals. This model allows diagnostic information to be efficiently 
compressed in the first few LV‟s. The dichotomous PLS-DA algorithm can be 
extended to multi-class classification using one-against-one or one-against-all scheme 
with max-wins voting or other voting strategies.
91
 Many useful extensions of PLS for 
optimization exist including Interval PLS-DA, PLS-GA etc.
84
   
 
2.4.4 Diagnostic performance validation 
Independent validation is necessary to obtain accurate estimates of diagnostic 
algorithm performance. This is however not always possible due to practical 
considerations (e.g., limited data size, economic reasons etc.). Hence to estimate the 
performance (i.e., accuracy, sensitivity and specificity) of algorithms (and determine 
optimal algorithm complexity for PCA or PLS-DA etc.), leave-one-out cross-
validation can be employed.
82
 In this technique, spectra from one patient (or site) are 
left out and the model is rebuilt with the remaining spectra. The left-out spectra are 
then predicted and this is repeated iteratively through all patients/sites to obtain an 
estimate of diagnostic algorithm performance. Independent block validation can also 
25 
be performed by splitting the dataset into training (e.g., 80% of dataset) and testing 
(e.g., 20% of dataset) and this can be repeated iteratively to obtain confidence in the 
estimates.
43
 In this dissertation, we also employ receiver operating characteristics 
curves (ROC).
92
 ROC analysis offers efficient tools to select optimal classification 
models. ROC curves are calculated by changing the classification thresholds and 
plotting the sensitivity as a function of 1-specificity. The area under the curve (AUC) 




2.4.5 Biomolecular and spectral modeling 
Biological Raman spectra are intrinsically complex to interpret due to a 
multitude of overlapping peaks mainly of protein, lipids and DNA.
25
 However, to 
evaluate gross quantitative differences between different biological tissue types, semi-
quantitative spectral modelling of the tissue Raman spectra using basis reference 
biochemicals can be employed.
93
 The non-negativity least squares minimization 
(NNLSM) modelling can be used to grossly fit representative biochemicals to the 
tissue Raman spectra (Equation [6]) 
                                  X = cS+E  where c ≥ 0,    [6] 
Where c is the fit-coefficients, S are the basis spectra, E are the residuals and X are 
the tissue Raman spectra, The resulting fit-coefficients are constrained to a total sum 
of 100% so that relative variations in tissue can be evaluated. One should note that 
biochemical modelling of tissue spectra by means of NNLSM is a linear semi-
quantitative estimation of biochemical compositions. Only the most essential 
biochemical constituents of tissue (i.e., biochemicals largely representing cell nucleus, 
cell cytoplasm, and intra-/extra-cellular matrices) should be included in the NNLSM 
26 
modeling. The discrepancy between the reconstructed Raman spectra (i.e., by the 
NNLSM modeling) and the measured Raman spectra may be due to the following 
reasons: (i) The ex vivo biomolecular compositions and conformations used for 
NNLSM modeling may not truly reflect in vivo tissue conditions; (ii) The basis 
spectra are not orthogonal, and an incomplete number of biochemicals are included; 
(iii) The  NNLSM biochemical modeling does not take the effect of tissue optical 
properties (e.g., absorption and scattering coefficients, and anisotropy) of different 
tissues into consideration; (iv) The laser penetration depth may also affect the 
estimated distributions of the biochemicals in different tissue types. Nevertheless, this 
semi-quantitative spectral analysis can give a fair estimate of the overall protein, lipid 




2.5 Overview of in vivo Raman endoscopy literature studies 
Accumulating evidence has confirmed the clinical potential of Raman spectroscopy ex 
vivo. A large number of ex vivo Raman spectroscopy studies on excised tissues and 
cells have been reported on the GI system.
26-31
 For instance, Stone and co-workers 
have characterized esophageal cells and tissue specimens associated with Barrett‟s 
disease.
37, 94-97
 Raman microspectroscopy was used to map the biomolecular 
distribution of protein, lipid and DNA in sectioned esophageal tissue samples, 
revealing the distinct biomolecular features associated with Barrett‟s carcinogenesis.94 
Our group has reported a series of ex vivo tissue Raman studies on gastric tissues.
26-31
 
For instance, Teh et al., reported the differentiation among different types of 
pathologic gastric tissues (e.g. HP infection, IM, dysplasia, neoplasia as well as 
differentiation between diffuse and intestinal-type adenocarcinoma) with good 
accuracies (of ~85–96%).26-31 Raman spectroscopy has also shown promising results 
27 
for differential diagnosis between adenomatous and hyperplastic polyps in the colon 
ex vivo.
83, 98
 Wilson and co-workers
69, 70, 99-102
 reported a Raman study on eight 
patients, showing that Raman spectroscopy could distinguish adenomatous from 
hyperplastic polyps ex vivo with 91% sensitivity and 95% specificity. In general ex 
vivo studies have been used to evaluate the diagnostic capability and characterize 
different tissue types using the highly specific Raman peaks. Since the Raman peaks 
of tissue and cells (mainly of protein, DNA and lipids) are superimposed, assignments 
of biochemicals/biomolecules and vibrational modes are tentative in nature. Table 1 
summarizes the location of the most prominent tissue Raman peaks in the spectral 
range (400-3600 cm
-1
) reported from the literature (accuracy of ~1-3 cm
-1
) with 
tentative vibrational/biomolecular assignments. The position of these specific Raman 

















509 υ(S–S) of proteins  104 
669 υ(C–S) of cystine 96 
752 Ring breathing mode of tryptophan  
25
 
782 υ(O–P–O) of DNA 105 
853  υ(C–C), proline 25 
875 υ(C–C), hydroxyproline of proteins  27, 28 
936 υ(C–C), α-helix, proline, valine 25 
956 υs(P=O) of hydroxyapatite, bone 
106, 107
 





1078 υ(C–C) of lipids 25 




1245 υ(C–N), δ(N–H) Amide III 27 




1335 CH3CH2 wagging mode of proteins 








1420 Adenine, guanine (DNA, RNA) 
110
 







1579 Guanine of DNA 
96, 109
 
1618 υ(C=C) of porphyrins (hemoglobin) 28 
1638 υ2 bending mode of water 
112
 
1655 υ(C=O) Amide I of proteins 25, 27, 93 
1745 υ(C=O) of phospholipids 27, 93 
2850 υs(CH2) of lipids 
113-115
 
2885 υas(CH2) of lipids 
113, 116
 
2939 υ(CH2) of proteins 
113
 
3011 υ(=C–H) of lipids 113, 114 
3232 υ(O–H) and υ(N–H) vibrations of 
water and proteins 
113
 
3400 υ(O-H) vibrations of water 113, 116, 117 
 





While tissue characterization and peak assignments remain important fields in 
biomedical Raman spectroscopy, the ultimate goal is clinical in vivo implementation. 
To move the Raman technique into medical diagnosis at endoscopy, Shim et al. 
29 
pioneered the in vivo fiber-optic Raman spectroscopy technique for GI endoscopic 
applications,
70, 102
 and demonstrated the capability of Raman spectroscopy for the 
differential diagnosis between adenomatous and hyperplastic polyps in the colon in 
vivo with a sensitivity of 100% and specificity of 89%.
118
 However, Raman 
acquisition times in their Raman system design was lengthy (>5 sec), which was 
impractical for routine real-time endoscopic applications.
64
 Hence, additional 
technological development was needed to transfer Raman spectroscopy into clinical 
endoscopy. With very recent technological advancements in Raman spectroscopy 
instrumentation, including high-throughput spectrographs, NIR lasers, sensitive CCD 
cameras, personal computers and fiber-optic Raman probes, significant progress has 
been made in translating Raman spectroscopy into real-time in vivo routine 
endoscopic applications. Accumulating evidence from different organs has now 
confirmed the clinical potential of Raman spectroscopy in vivo.
43, 50, 78, 89-91, 106, 112, 119-
125
 Table 2 summarizes the in vivo studies and most important experimental 
parameters and results reported from different endoscopic accessible organs (i.e., 



























Integration time: <1 s  
Identification of laryngeal cancer 
with a sensitivity of 90.3% and a 










Integration time: 5 s  
 
Dysplastic BE could be 
differentiated from non-dysplastic 
BE with a sensitivity of 86% and a 











Integration time: <0.5 s  
Sensitivity of 90.9% and a 
specificity of 93.9% using PLS-DA 









Integration time: <0.5 s  
Sensitivity of 97.0% and a 
specificity of 95.2% for cancer 









Integration time: <0.5 s 
Prospective diagnostic sensitivity of 
87.0% and specificity of 84.7% can 
be obtained for in vivo detection of 
HGD in BE using the PLS-DA 








Integration time: <0.5 s  
Sensitivity of 94.4% and a 
specificity of 96.3% for detecting 










Integration time: <0.5 s  
Sensitivities of 90.8%, 84.7%, 
82.1%, and specificities of 93.8%, 
94.5%, 95.3% for classification of 
normal, benign and malignant gastric 









Integration time: <0.5 s  
Sensitivity of 92.6% and a 
specificity of 88.6% for gastric 










Integration time: <0.5 s  
Sensitivity of 97.9% and a 
specificity of 91.5% for cancer 










Integration time: <0.5 s  
Prospective sensitivity of 90.0% and 
specificity of 73.3% based on the 
generated PLS-DA model from the 
spectral library (2748 spectra 
measured from 305 patients) for 







Table 2 Summary of reported in vivo Raman spectroscopic studies for the diagnosis of endoscopic 
precancers and cancers to date. Important experimental parameters and results are given. 
 
 
Besides in the GI tract, Raman spectroscopy has shown promising potential in 
other endoscopic accessible organs. For instance, Zeng and co-workers have 
developed an image-guided Raman endoscopic system for bronchoscopic 
applications.
129
 They conducted a study based on 46 patients, and reported that Raman 
endoscopy complements WLR and AFI by reducing the false positives biopsies.
127
 
WLR+AFI and Raman endoscopy showed sensitivity and specificity of 96% and 91% 
respectively for detecting the preneoplastic lesions.
127
 Their study was however not 
randomized. Draga et al. conducted an in vivo Raman study on 38 patients in the 
bladder during the procedure of transurethral resection of bladder tumors (TURBT), 
and found that Raman spectroscopy could differentiate bladder cancer from normal 
tissue with a sensitivity of 85% and a specificity of 79%.
128
 Very recently, our group 
has reported on the implementation of transnasal Raman endoscopy of 
nasopharyngeal and laryngeal tissues.
112
 Our group conducted a study on 39 patients 
and measured a total of 94 Raman spectra.
115
 Raman spectra from tumors showed 






Integration time: <0.5 s  
PLS-DA algorithm detects IM, 
dysplasia and cancer with 
sensitivities of 46.67%, 83.33%, 
84.91% and specificities of 87.55%, 




Colon 3 patients 
19 spectra 
 
Excitation power: 100 
mW 
Integration time: 5 s  
 
Sensitivity of 100% and specificity 
of 89% for discriminating adenoma 








Maximum excitation  
power: 200 mW 
Integration time: 1 s  
Sensitivity of 96% and a specificity 
of 91% using PCA-LDA for 




Bladder 38 patients 
63 spectra 
 
Excitation power: 56-89 
mW 
Integration time: 1-5 s 
Sensitivity of 85% and specificity of 
79% for detecting bladder cancer 





distinct spectral characteristics, and could be diagnosed on spectrum basis with a 
sensitivity of 90.3% and a specificity of 90.9%. In general Raman spectra are highly 




Chapter 3. Outline of clinical study protocols 
The present study was conducted in close collaboration with the Endoscopy 
Centre at the National University Health System (NUHS), Singapore, and is part of a 
continuous nationwide study focusing on early diagnosis and treatment of 
gastrointestinal malignancies run by the Singapore Gastric Cancer Epidemiology, 
Clinical and Genetic Program (GCEP). GCEP aims to identify an optimum approach 
and cost-effective measures for targeted screening of gastric cancer in the local 
population. The GCEP Cohort Study for subjects at high risk of gastric cancer was 
initiated in January 2004, with a planned enrollment of 4000 well-characterized high-
risk patients undergoing systematic screening for early gastric cancer, supported by an 
annotated clinical database and the banking of high-quality gastric tissue and plasma 
specimens. The GCEP Cohort Study enrolls people aged >50 years who are at high 
risk of gastric cancer and offers screening by endoscopy with systematic prospective 
follow up over a minimum of 5 years. Participation is voluntary and participants 
receive detailed explanation and counseling on the benefits of the study, as well as the 
requirements of the study. This study has been approved by the Institutional Ethics 
Review Boards (IRB) in four major hospitals in Singapore. The study captures 
comprehensive clinical information on a state-of-the-art database, and obtains 
prospectively blood, serum, white-blood-cell DNA, gastric biopsy tissue, and gastric-
juice samples according to a standardized protocol.  
 
This Raman work was approved by the Institutional Review Board (IRB) of 
the National Healthcare Group (NHG) of Singapore. The trial was performed in 
accordance with International Conference on Harmonization (ICH) for Good Clinical 
Practice (GCP) guidelines, Declaration of Helsinki (2000). All participants were 
34 
orally informed and have signed a written informed consent. The study protocols, 
written informed consents, and record holdings are stored by the Gastrotranslational 
Office, NUHS. Raman spectral data are stored in a database in the Department of 
Biomedical Engineering, Bioimaging Laboratory, National University of Singapore 
(NUS). A supplementary (SR) protocol is used to recruit in-patients at the Endoscopy 
Center, NUHS. From August 2008 to June 2013, a total of 450 patients have been 
enrolled in the Raman endoscopic examinations at NUHS. We have systematically 
conducted Raman measurements of both the esophagus and gastric from these 
patients. Over 12,000 Raman spectra have been measured. The histopathological 
examinations from Department of Pathology, NUHS served as the gold standard for 
evaluating the diagnostic sensitivity and specificity of in vivo Raman endoscopy 
technique. The data presented in this dissertation (Chapter 4, Chapter 5, Chapter 6 and 
Chapter 7) has been analyzed continuously when accumulating in vivo Raman spectra 













Chapter 4. Characterizing variability in in vivo Raman 
spectra of different anatomical locations in the upper 
gastrointestinal tract toward cancer detection 
This chapter aimed to develop the fiber-optic Raman endoscopy technique and 
characterize in vivo Raman spectroscopic properties of tissues belonging to different 
anatomical regions in the upper GI tract and explore the implications for early 
detection of neoplastic lesions during clinical gastroscopy. A novel fiber-optic Raman 
endoscopy technique was developed and applied for real-time in vivo tissue Raman 
measurements of normal esophageal (distal, middle, and proximal), gastric (antrum, 
body, and cardia) as well as cancerous esophagous and gastric tissues from 107 
patients who underwent endoscopic examinations. The NNLSM coupled with a 
reference database of Raman active biochemicals (i.e., actin, histones, collagen, DNA, 
and triolein) was employed for semiquantitative biomolecular modeling of tissue 
constituents in the upper GI.  
A total of 1189 in vivo Raman spectra were analyzed from different locations in 
the upper GI. The Raman spectra among the distal, middle, and proximal sites of the 
esophagus showed no significant interanatomical variability. The interanatomical 
variability of Raman spectra among normal gastric tissue (antrum, body, and cardia) 
was subtle compared to cancerous tissue transformation, whereas biomolecular 
modeling revealed significant differences between the two organs, particularly in the 
GE junction. Cancerous tissues could be identified across interanatomical regions 
with accuracies of 89.3% (sensitivity of 92.6% (162/175); specificity of 88.6% 
(665/751)), and of 94.7% (sensitivity of 90.9% (30/33); specificity of 93.9% 
(216/230)) in the gastric and esophagus, respectively, using PLS-DA together with the 
36 
leave-one tissue site-out, cross validation. This chapter demonstrates that Raman 
endoscopy technique has promising clinical potential for real-time, in vivo diagnosis 
and detection of malignancies in the upper GI at the molecular level. 
4.1 Introduction 
We present an integrated Raman spectroscopy and trimodal (WLR, NBI, AFI) 
imaging technique for real-time in vivo tissue Raman measurements at endoscopy. A 
special 1.8 mm endoscopic Raman probe with filtering modules is developed, 
permitting effective elimination of interference of fluorescence background and silica 
Raman in fibers while maximizing tissue Raman collections. High-quality in vivo 
Raman spectra of upper gastrointestinal tract can be acquired within 1 s or subseconds 
under the guidance of wide-field endoscopic imaging modalities, greatly facilitating 
the adoption of Raman spectroscopy into clinical research and practice during routine 
endoscopic inspections. The histological characteristics and morphologies of 
distinctive anatomical regions in the upper GI tract (i.e., esophagus and gastric) are 
highly functionally specialized and exhibit significant variations in architectural 
properties and cell types (e.g., tissue thickness variability, distinct glandular types, 
secretion products, vascularity, etc.)
130, 131
. Hence, to assess the potential of Raman 
endoscopy technique, the extent of in vivo Raman spectral interorgan and 
interanatomical variabilities of tissues in the upper GI tract must be validated. Hence, 
the main aim of this study was to evaluate the magnitude of interorgan and 
interanatomical variability of in vivo normal tissue Raman endoscopic spectra in the 
esophagus and gastric as well as to assess the implication for early diagnosis of 
neoplastic lesions. The semiquantitative biomolecular modeling NNLSM
132
 using 
representative biochemical basis spectra is also employed for estimation of the most 
prominent Raman active constituents of tissue in the upper GI tract. 
37 
 
4.2 Materials and methods 
4.2.1 Instrumentation 
The novel integrated Raman spectroscopy and trimodal wide-field imaging 
system developed for in vivo tissue measurements and characterization at endoscopy 
is shown in Figure 4.1 and consists of a wavelength stabilized 785 nm diode laser 
(maximum output: 300 mW, B&W TEK Inc., Newark, DE), a transmissive imaging 
spectrograph (Holospec f/1.8, Kaiser Optical Systems) equipped with a liquid-
nitrogen cooled, NIR-optimized, back-illuminated, and deep depletion charge-coupled 
device (CCD) camera (1340×400 pixels at 20×20 μm per pixel; Spec-10: 400BR/LN, 
Princeton Instruments), and a specially designed 1.8 mm Raman endoscopic probe for 
both laser light delivery and in vivo tissue Raman signal collection.  
 
Figure 4.1 (a) Schematic of the integrated Raman spectroscopy and trimodal endoscopic imaging 
system developed for in vivo tissue Raman measurements at endoscopy; (b) Photo of the Raman 
endoscopic system in clinic; (c) Photo of the fiber-optic Raman endoscopic probe. 
 
The novel Raman probe is composed of 32 collection fibers (200 µm, NA: 0.22) 
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surrounding the central light delivery fiber (200 µm, NA: 0.22) with two stages of 
optical filtering incorporated at the proximal and distal ends of the probe for 
maximizing the collection of tissue Raman signals while reducing the interference of 
Rayleigh scattered light, fiber fluorescence, and silica Raman signals. The Raman 
probe can pass down through the instrument channel of most medical endoscopes and 
be directed to all anatomical tissue sites under the guidance of wide-field endoscopic 
imaging (WLR/AFI/NBI) modalities
64
 and the probe positioning against the mucosa 
can be verified on the endoscopy monitor by the clinicians in-charge during 
endoscopic examinations. Control of the in vivo Raman endoscopy system was 
implemented by a personal computer (PC) using custom-designed software that 
triggers on-line data acquisition and analysis (e.g., CCD dark-noise subtraction, 
wavelength calibration, system spectral response calibration, signal saturation 
detection, cosmic ray rejection, etc.), as well as real-time display of in vivo tissue 
Raman spectra during clinical endoscopic measurements. 
 The atomic emission lines from a mercury-argon spectral lamp (HG-1, Ocean 
Optics, Inc., Dunedin, FL) are used for wavelength calibration of tissue Raman 
spectra, and all wavelength-calibrated spectra were corrected for the wavelength-
dependence of the system using a tungsten-halogen calibration lamp (RS-10, EG&G 
Gamma Scientific, San Diego, CA). The spectral resolution of the Raman system is 
9 cm-1 and the system acquires Raman spectra in the wavenumber range of 800–
1800 cm
-1
 from in vivo GI tissue within 0.5 s using the 785 nm excitation power of 
1.5 W/cm
2
, which is less than the maximum permissible skin exposure limit set out by 
the American National Standards Institute.
74
 This presumes the presence of melanin. 
Our further calculations based on the finite difference thermal model and the optical 
properties of the GI tissue
133, 134
 indicate that even without consideration of other 
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cooling effects (e.g., perfusion and evaporation in tissue), the maximum tissue 
temperature rise is only about 0.15 ◦C after 1 min of 785 nm laser radiation with an 
incident power of 30 mW on a tissue spot size of 200 μm during tissue Raman 
measurements. This temperature rise estimated is far below the level to generate 
cytotoxicity in cells and tissue,
74
 suggesting that the laser power density used in this 
study is safe for in vivo tissue Raman measurements in the upper GI.  
 
Figure 4.2 (a) Photograph of Raman endoscopy system in clinic; (b) insertion of the 1.8 mm 
Raman endoscopic probe into the working channel of an endoscope during gastroscopy; and (c) 
routine Raman endoscopy procedure in clinic. 
 
The trimodal endoscopy imaging system comprises a 300 W short-arc xenon 
light source, a gastrointestinal videoscope (GIF-FQ260Z, Olympus), and a video 
system processor (CV-260SL, Olympus). The light reflected or autofluorescence 
emitted from tissue are detected by two monochrome CCD chips mounted behind the 
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two objective lens placed next to each other at the distal tip of the GI videoscope: one 
CCD for WLR/NBI and the other one for AFI. With this unique image-guided Raman 
endoscopy system, wide-field endoscopic images (WLR/AFI/NBI) and the 
corresponding in vivo Raman spectra of the tissue imaged can be simultaneously 
acquired, displayed, and recorded in the video system processor and the PC, 
respectively. We have also integrated the system on a cart (Figure 4.2) with an 
axillary power unit (APU) that makes the Raman spectroscopy system movable in 
clinical settings.  
4.2.2 Preprocessing 
The raw Raman spectra (800–1800 cm-1) measured from in vivo GI tissue 
represents a composition of weak Raman signals, intense autofluorescence 
background and noise.
64
 Thus, the raw spectra were preprocessed by a first-order 
Savitsky-Golay smoothing filter (window width of five pixels, which corresponded to 
the system spectral resolution) to reduce noise.
64
 A fifth-order polynomial was found 
to be optimal for fitting the autofluorescence background in the noise-smoothed 
spectrum,
64
 and this polynomial was then subtracted from the raw spectrum to yield 
the tissue Raman spectrum alone. Each background-subtracted Raman spectrum was 
also normalized to the integrated area under the curve from 800–1800 cm−1, enabling 
a better comparison of the spectral shapes and relative Raman band intensities among 
different organs and anatomical regions.  
4.2.3 Study protocol 
Outline of the clinical study protocol used can be found in Chapter 3. In this 
study, spectra from 107 patients (61 men and 46 women with a median age of 66 
years old) were analyzed.
64 A total of 1189 in vivo Raman spectra were acquired and 
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analyzed from the upper GI tract including normal (antrum sites with greater and 
lesser curvatures, body sites with greater and lesser curvatures, and cardia) and 
cancerous gastric tissues, as well as normal (distal end, middle sites, and proximal 
sites) and cancerous esophageal tissues. Table 3 summarizes the number of in vivo 
Raman spectra acquired and the corresponding integration time required for each 
tissue type in the upper GI.  
 
Table 3 The number of in vivo Raman spectra acquired and the corresponding mean integration 
time required for each tissue type in the gastric and esophagus. 
 
Immediately after Raman endoscopic acquisitions, the biopsies were taken from the 
tissue sites measured (with suction markings) and fixed in 10% formalin solution for 
histopathological confirmation of normal or malignant tissue types by a senior 
gastrointestinal pathologist who was blinded to the Raman spectroscopy results. Note 
that the cancerous gastric tissues (adenocarcinomas (n = 175)) were found in different 
sites (e.g., antrum/body/cardia) of the stomach; whereas cancerous esophageal tissues 
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(including adenocarcinomas (n = 26) and squamous cell carcinoma (n = 6)) were 
localized in the distal and middle parts of the esophagus, respectively. The 
histopathological examinations served as the gold standard for evaluating the 
diagnostic sensitivity and specificity of in vivo Raman endoscopy technique.  
 
4.2.4 Biomolecular modeling 
The biomolecular characterization of esophageal and gastric tissue is essential 
for implementation of the Raman endoscopy technique as a clinical tool for in vivo 
diagnosis of cancer and precancer in the upper GI. The biochemical spectral fitting by 
means of Raman spectra of cell constituents (e.g., cytoplasm, nucleus, etc.) and pure 
biochemicals has been extensively employed to gain better understanding of 
distinctive tissue constituents associated with pathologic changes.
94, 122, 132
 In this 
chapter, we employ a semiquantitative model of in vivo tissue Raman spectra based 
on a priori insight of inter-/intra-cellular constituents using a linear combination (i.e., 
NNLSM)
132
 of basis Raman spectra that represent the main biochemical constituents 
in the GI tract. Of over 35 basis reference Raman spectra obtained from different 
biomolecules associated with GI tissue (e.g., actin, albumin, pepsin, pepsinogen, 
nicotinamide adenine dinucleotide (NADH), RNA, DNA, myosin, hemoglobin, 
collagen I, collagen II, collagen V, mucin 1, mucin 2, mucin 3, flavins, elastin, 
phosphatidylcholine, cholesterol, glucose, glycogen, triolein, histones, beta-carotene, 
etc.), our NNLSM modeling indicate that the following five biochemicals, i.e., actin 
(A3653), histones (H6005), collagen type I (C9879), DNA (P4522), and triolein 
(T7140) (Sigma, St Louis, MO), were the most significant Raman-active biochemical 
constituents (Figure 4.3) that can effectively characterize gastric and esophageal 
(normal and cancerous) tissue with very small fit-residuals. For instance, DNA 
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represents nucleic acids within the cell nucleus; triolein represents typical lipid 
signals; actin and histones resembles proteins of different conformations and are the 
major components of the cytoskeleton and chromatin, respectively, whereas collagen 
type I is a substantial part of the extracellular matrix. Note that the basis Raman 
spectra of these biochemicals were measured in their native conditions without any 
further purification using the Raman endoscopy instrumentation previously described 
for semiquantitative biochemical modeling. The five coefficients rendered using 
NNLSM were further constrained to a sum of 100% to assess relative changes. 
 
Figure 4.3 The five basis reference Raman spectra (i.e., actin, collagen, DNA, histones, and 
triolein) are used for biochemical modeling of esophageal and gastric tissue. 
 
4.3 Results  
High quality in vivo Raman spectra can routinely be acquired from different 
anatomical locations or lesion sites within the esophagus and gastric in real-time (<0.5 
s) under multimodal imaging (WLR, NBI, and AFI) guidance during clinical 
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endoscopic examinations. Figure 4.4a shows the in vivo mean Raman spectra ± 1 
standard deviations (SD) of normal (antrum, body, and cardia) and cancer gastric 
tissues; whereas Figure 4.4b shows the in vivo mean Raman spectra of cancer and 
normal (distal, middle, and proximal) esophageal tissues.  
 
Figure 4.4 (a) In vivo mean Raman spectra ± 1 SD of normal (antrum, body, and cardia) and 
neoplastic gastric tissues. (b) In vivo mean Raman spectra ± 1 SD of the normal (distal, middle, 
and proximal) and neoplastic esophageal tissues. Note that the mean Raman spectra are vertically 
shifted for better visualization. 
 
The Raman signals of the esophageal and gastric mucosa were reproducible among 
different patients. Prominent Raman bands are observed in both organs in the 
following peak positions with tentative biomolecular assignments (Table 1):
26-31, 89, 120 
853 cm
-1 υ(C–C) of proteins, 936 cm-1 υ(C–C) of α-helix conformation for proteins, 
1004 cm
-1 υs(C–C) ring breathing of phenylalanine, 1078 cm
-1 (υ(C–C) stretching 
mode of lipids), 1265 cm
-1 Amide III υ(C–N) and δ(N–H) of proteins, 1302 and 1335 
cm
-1 δ(CH2) deformation and CH2CH3 twisting of proteins and nucleic acids, 1445 
cm
-1 δ(CH2) of proteins and lipids, 1618 cm
-1
 (υ(C=C) stretching mode of 
porphyrins), 1655 cm





Figure 4.5 Difference spectra ± 1 SD comparing different anatomical regions and tissue types of 
the (a) gastric and (b) esophagus tissue. (c) Difference spectrum of the distal end of the esophagus 
and the cardia in the stomach, resolving inter-organ variability at the molecular level. 
 
The difference spectra ± 1 SD between different tissue types (Figure 4.5a and Figure 
4.5b) clearly resolve the subtle interanatomical variations and the major biochemical 
changes associated with cancer transformation; whereas Figure 4.5c reveals important 
biochemical differences between the two organs within the GE junction (i.e., the 
distal end of the esophagus and cardia in the stomach). One-way analysis of variance 
(ANOVA) with Bonferroni correction at 5%
28, 29
 was separately employed for each 
organ (normal tissue). Table 4 summarizes the six significant Raman peak positions 
identified as well as the corresponding p-values generated from the post-hoc Fisher‟s 
least significant difference (LSD) test
28, 29 of all pair-wise anatomical regions in 
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normal gastric tissue (i.e., antrum versus body; body versus cardia; antrum versus 
cardia). Similar statistical analysis did not find significant interanatomical variability 
of normal tissues within the esophagus (i.e., distal, middle, and proximal); whereas 
significant spectral changes (p < 1.0 × 10
-6
) were found between the two organs 
(distal esophagus versus cardia), particularly at 1078, 1150, 1197, 1302, 1409, 1455, 
and 1745 cm
-1
. One notes that no significant interanatomical variability (p > 0.1) of 
malignant tissues in the upper GI was found by Raman endoscope technique, which is 
probably due to the reason that the sizes of the tumor tissues measured in the 
esophagus and gastric are much larger than the probing volume (∼1 mm3) of our 




Table 4 The significance (p-value) of the distinctive Raman peaks identified (one-way ANOVA 
with Bonferroni correction at 5%) from in vivo normal gastric tissues (antrum, body, and cardia) 





Figure 4.6 Comparison of the in vivo Raman spectra measured with the reconstructed tissue 
Raman spectra through the employment of the five basis reference Raman spectra: (a) normal 
esophagus, (b) esophageal cancer, (c) normal gastric, (d) gastric cancer. Residuals (measured 
spectrum minus fit spectrum) are also shown in each plot. 
 
To characterize the spectral contribution from important Raman active tissue 
constituents (e.g., proteins, DNA, and lipids) in gastric and esophageal tissue types, 
the NNLSM was subsequently employed for semiquantitative modeling using the five 
basis reference spectra acquired as shown in Figure 4.3 (i.e., actin, collagen type I, 
DNA, histones, and triolein). Figure 4.6 shows the comparisons of the mean measured 
Raman spectra and the reconstructed Raman spectra of different tissues (i.e., gastric 
normal/cancer and esophageal normal/cancer). The residual variations of the NNLSM 
model rendered from each of the tissue sites in the gastric and esophagus are listed in 
Table 5. The fit-residuals between the reconstructed and the measured Raman spectra 
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are of less than 10%, indicating that the five tissue biochemical constituents used in 
NNLSM modeling can largely account for most information contained in tissue 
Raman spectra of the upper GI. To further assess the validity of biomolecular 
modeling for tissue characterization, we rendered difference spectra ± 1 SD of the 
reconstructed Raman spectra for estimating the similarities with the measured 
difference spectra. Figure 4.7a-b display the relative Raman spectral contribution of 
the five biochemicals of different tissue sites in the gastric and esophagus together 
with the corresponding p-value reflecting subtle interanatomical Raman spectral 
changes while significant differences associated with tissue carcinogenesis processes.  
 
 
Table 5 Residual variations in absolute numbers of the NNLSM model rendered from each of the 




Figure 4.7 Histogram displaying the average biochemical spectral contributions to the different 
tissue types in the (a) gastric and (b) esophagus tissue. The one SD are shown for each model 
component. Note: * indicates a significant differences (p < 1.0×10
-3
); whereas ** indicates a 





In this chapter we developed a novel multimodal image-guided Raman 
endoscopic technique and reported on the in vivo gastric tissue characterization. With 
a specially designed miniaturized Raman endoscopic probe,
64 which can fit into the 
instrument channel of medical endoscopes for effective excitation and collection of 
tissue Raman scattered photons, the clinicians are now able to nondestructively assess 
the endogenous biochemical and morphological information of internal tissues under 
the wide-field endoscopic imaging (WLR, NBI, and AFI) guidance. Unlike in vitro 
Raman spectroscopy,
26-31 the image-guided Raman endoscopic technique can provide 
real-time biochemical assessment of tissues in situ (e.g., free of artifacts introduced by 
mechanically cutting, oxidation, hydration, loss of mucus layer, and vascular pressure, 
etc.) and therefore offer Raman endoscopy as a possible routine diagnostic tool in the 
esophagus and gastric. However, as the interanatomical regions of the esophagus and 
particularly the gastric tissue are highly biological and functionally specialized (e.g., 
thickness variability, distinct glandular types, secretion products, vascularity, etc.),
130, 
50 
131 it is essential to figure out, to what extent, the effect of interorgan and 
interanatomical tissue sites‟ variations may affect the diagnostic algorithm 
developments of the Raman endoscope technique.
 
In this chapter, we evaluate for the first time in vivo Raman spectral properties 
of different anatomical regions of normal gastric and esophageal tissues. We have 
identified distinct Raman bands in both organs that are highly associated with 
proteins, DNA, and lipids (Figure 4.4). The difference spectra (Figure 4.5a-b) resolve 
the subtle interanatomical variability, indicating that the overall biomolecular and 
biochemical constituents of different normal tissues are very similar, whereas 
neoplastic tissues exhibit distinctive Raman spectral profiles (e.g., Raman peaks 
shifting, bandwidths broadening, or narrowing, relative Raman peak intensity 
changes). Further Raman spectral analysis also reveals significant spectral differences 
of tissues within the GE junction (Figure 4.5c), confirming the promising ability of 
Raman endoscopy for the sensitive characterization of morphological and 
biomolecular constituents in the upper GI tract. The Raman active biochemical 
profiles of gastric and esophageal tissue types were further assessed by rendering 
semiquantitative models constructed from essential biochemical constituents of 
gastric and esophageal tissues. For instance, proteins were found to be the most 
prominent contributors in in vivo tissue Raman spectra, which are similar to the in 
vitro tissue studies.
23, 94, 135
 The difference spectra (Figure 4.5) also reflected large 
interpatient variations in the subregions 1078 υ(C–C) and 1440 cm-1 δ(CH2) 
deformation, which are highly associated with signals from proteins and lipids, as 
confirmed by biochemical modeling. Moreover, the statistical analysis indicated 
subtle but complex differences in signals originating from proteins, lipids, and DNA 
of the antrum as compared to the body and cardia sites of the stomach. These 
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distinctive spectral features of the body likely reflect the intricate morphology
130
 and 
biomolecular compositions of the body regions that constitute highly specialized cells 
(e.g., zymogenic and oxyntic cells in a densely packed architecture secreting acids, 
enzymes, etc.).
130 For instance, the relatively less collagen of the body site compared 
to antrum as revealed by biomolecular modeling (p = 6.2×10
-2
) could be associated 
with the closely packed morphologic structures containing less connective tissue. We 
also found that the in vivo Raman spectrum of cardia resembled the body region, 
which might be caused by the endoscopically poor defined and narrow zone of the 
cardia region and gradual transitional mucosa with cardia pathology-slides 
occasionally bearing resemblance with body histology (e.g., presence of oxyntic cell 
types).
130
 But the difference spectra (Figure 4.5b) and statistical analysis indicated no 
statistically significant interanatomical variability of normal tissues within the 
esophagus (p > 0.1), confirming that the relatively thick squamous epithelium (∼10–
20 cell layers) is approximately identical among the distal, middle, and proximal 
regions of the esophagus.
131 Our Monte Carlo simulations
125
 have indicated that the 
785 nm laser light penetration depth from the Raman endoscopic probe developed is 
∼750–800 μm with a 200 μm beam size on the tissue surface, which is well within the 
lamina propria (the thickness of squamous epithelium is ∼300–500 μm) of the 
esophagus.
131 Since most of the collected Raman scattered light originates from the 
shallower layer of the mucosa (e.g., epithelium) in which early neoplastic tissue 
transformation (e.g., dysplasia, carcinoma in situ) is most likely to originate, our 
fiber-optic Raman endoscopic probe still ensures a relatively small probing volume 
(of less than 1 mm
3
 in tissue volume) covering the epithelium tissue layer, which 
permits the Raman evaluation of precancer and early cancer in the upper GI. On the 
other hand, the difference spectrum (Figure 4.5c) of normal distal esophagus and 
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gastric cardia within the GE junction exhibits significant Raman peaks shifting, 
bandwidths broadening/narrowing, and relative Raman peak intensity changes with 
the most prominent features at 1078, 1150, 1197, 1302, 1409, 1455, and 1715 cm
-1
, 
while the NNLSM modeling suggests a complex variation in Raman spectral 
contributions of proteins DNA and lipids of different organs. These observations 
relate to the characteristic morphological architectures of the distinctive epithelial 
types (i.e., columnar lined versus nonkeratinized squamous epithelia) and glandular 
architectures etc. belonging to different organs
130, 131
 as they were also visible under 
wide-field imaging observations (in particular NBI). The biochemical modeling 
indicates a considerably elevated content in lipids of the distal esophagus as compared 
to the gastric cardia (p = 3.2×10
-6
), which is in agreement with the reports on 
accumulations of lipids in the dense cell layers of the esophageal epithelium, as a part 
of the mucosal barrier.
136 Further, the relative less collagen of the esophagus 
compared to gastric is also linked with the thick squamous epithelium obscuring the 
Raman signal from the extensive connective tissues in the lamina propria. This optical 
filtering effect has also been observed in autofluorescence spectroscopy of gastric and 
esophageal neoplastic tissues as a result of the increased epithelial proliferation.
132, 137 
It is particularly interesting that we observed an inverse linear relationship 
(correlation coefficient R > 0.92) between collagen and triolein in the esophagus, 
suggesting that the large interpatient variation in the lipids signals could be connected 
with epithelial properties (e.g., thickness, lipid content)
136 within the esophagus. To 
further evaluate the clinical implications of interorgan variability, we also employed a 
classification algorithm (e.g., PLS-DA)
90 to exploit subtle spectral variations of the 
entire Raman spectra that are not resolved by biomolecular modeling. The 
classification accuracy of 87.1% (142/163) could be achieved based on the leave-one 
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tissue site-out, cross-validation method,
90
 proving that the Raman spectra reflect 
surface and subsurface tissue structures and biomolecular constituents. The 
differences in in vivo Raman spectra between neoplastic and nonneoplastic gastric 
tissues have also been reported in our previous gastric Raman studies.
89 The NNLSM 
modeling demonstrates that the neoplastic tissues show different contributions of 
distinctive biomolecules across interorgan and interanatomical regions in the upper 
GI, substantiating the important biochemical/biomolecular changes of tissues 
associated with carcinogenesis processes in situ. The significance of cancerous tissue 
transformation as compared to interanatomical variability in the gastric was further 
verified by ANOVA and post-hoc Fisher‟s LSD analysis (e.g., cancer versus normal 
gastric tissues (antrum, body, and cardia) with significant differences in the Raman 
bands: 936 (p < 2.1×10
-2
), 1245 (p < 5.5×10
-4
), 1335 (p < 3.7×10
-28
), 1618 (p < 
3.1×10
-31
), 1665 (p < 1.7×10
-25
), and 1745 cm
-1 (p < 2.1×10
-30
)). Particularly, the 
Raman peaks at 1575 and 1335 cm
-1
 are highly associated with increased DNA 
contents
122-124
 that were also confirmed by biomolecular modeling (Figure 4.7); 
whereas the increased Raman band intensity and the bandwidth broadening of the 
1655 cm
-1 amide I υ(C = O) vibration pertained to a higher content of α-helical 
proteins (e.g., histones, the main protein component that makes up the chromatin). 
Overall, these biomolecular changes suggest the increased nuclear activity (e.g., 
hyperchromatic state) in neoplastic tissue, which is among the main characteristics of 
tissue carcinogenesis and is of considerable pathological value for tissue diagnosis 
and characterization. The biomolecular modeling also shows a small decrease in 
collagen, which is in agreement with the reports that cancerous cells proliferate, 
invade into underlying stromal layer and express a class of metalloproteases, resulting 
in an overall reduction of collagen content in cancer tissue.
123, 124 The relative increase 
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in Raman signals from proteins (e.g., 1004, 1265, and 1655 cm
-1
) could also be 
related to increased mitotic activity,
137 while the reduction in Raman signals related to 
lipids (at 1078, 1302, 1440, and especially at 1745 cm
-1
) for precancer and cancer 
gastric tissues has also been found in our previous Raman studies.
78, 122, 132 On top of 
these, the Raman peak increase at 1575–1618 cm-1 is highly associated with 
angiogenesis process of neoplastic tissue,
78, 122, 132 which in fact, is reflected by the 
poor fitting ability of the NNLSM model in this spectral region due to the omission of 
Raman-active blood constituents (e.g., hemoglobin) in the basis reference set. Figure 
4.7a-b uncover the diagnostic significant fit coefficients for detection of neoplasms in 
the gastric and esophagus (e.g., actin, collagen, DNA, histones, and triolein); and the 
consistency in identifying similar diagnostic significant biochemicals across 
interorgans and interanatomical regions reconfirms the versatility of the Raman 
endoscopy for early detection and diagnosis of cancers based on Raman signals 
derived from proteins, DNA, and lipids. To further evaluate the clinical implications 
of interorgan variability, we also employed PLS-DA for cancer diagnosis whereby a 
diagnostic accuracy of 89.3% (sensitivity: 92.6% (162/175); specificity 88.6% 
(665/751)) and of 94.7% (sensitivity: 90.9% (30/33); specificity 93.9% (216/230)) in 
the gastric and esophagus, respectively, can be achieved based on the leave-one tissue 
site-out, cross validation method. The Raman spectral changes associated with 
cancerous tissue transformation (Figure 4.5) were several orders of magnitude larger 
than interanatomical variability of normal tissue, illustrating the efficacy of in vivo 
Raman endoscopy technique for early cancer diagnosis and detection in the upper GI. 
4.5 Conclusion 
High-quality in vivo Raman spectra can be acquired from different sites of the 
upper GI (i.e., gastric and esophagus) in real-time by Raman endoscopy technique 
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during clinical endoscopic examinations. Difference spectra together with 
biochemical modeling suggest that interorgan variability is significant whereas the 
interanatomical variability of the esophagus and gastric is subtle compared to 
neoplastic tissue transformation.  
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Chapter 5. Fiber-optic Raman spectroscopy probes gastric 
carcinogenesis in vivo at endoscopy 
Intestinal-type gastric carcinogenesis is a complex multi-step disease, and 
early precursors (e.g. IM and dysplasia) can be very challenging to identify using 
conventional white-light endoscopic imaging. In this chapter we assess the capability 
of the developed Raman spectroscopy technique for multi-class elucidation of 
intestinal-type gastric carcinogenesis sequence in vivo at endoscopy. We analyze 1277 
in vivo Raman spectra from 83 gastric patients associated with intestinal-type 
carcinogenesis. The results show that in vivo Raman spectroscopy integrated with 
semi-quantitative spectral modeling (e.g. DNA, lipids, glycoprotein, proteins and 
blood) reveals the progressive changes of biochemical constituents in gastric tissue 
associated with preneoplastic and neoplastic transformation (i.e., IM, dysplasia and 
adenocarcinoma). Multi-class probabilistic partial least squares-discriminant analysis 
(PLS-DA) diagnostic algorithms based on in vivo Raman spectra are able to identify 
normal mucosa with sensitivity of 75.88% and specificity of 87.21%; IM with 
sensitivity of 46.67% and specificity of 87.55%; dysplasia with sensitivity of 83.33%; 
specificity of 95.80%, and adenocarcinoma with sensitivity of 84.91% and specificity 
95.57%, respectively. This work demonstrates that Raman spectroscopy is a sensitive 
biomolecular probe for monitoring intestinal-type gastric carcinogenesis in vivo and 




5.1 Introduction  
Intestinal-type gastric cancer is a result of a multi-step disease pathway that is 
known to be associated with the intermediate transformation into IM phenotype 
before the progression to dysplasia and invasive carcinoma.
1, 3, 138
 Early identification 
and diagnosis of precancer and other precursors (e.g. IM) together with adequate 
treatment (e.g. endoscopic submucosal dissection (ESD) or HP eradication) is a 
critical measure to improving the survival rates of the gastric patients.
3
 However, 
endoscopic identification of IM, dysplasia and early flat cancer remain very difficult 
using conventional WLR imaging or NBI that heavily relies on gross morphological 
and microvascular manifestations at clinical endoscopy.
19, 139
 Our preceding NIR 
Raman spectroscopy studies of stomach tissue ex vivo have established the diagnostic 
foundation for detection and diagnosis of different types of pathologic gastric tissues 
(e.g. HP infection, IM, dysplasia, neoplasia, diffuse and intestinal-type 
adenocarcinoma) with good accuracies (of ~85 – 96%).26, 28-30 The clinical potential of 
Raman spectroscopy for multi-class identification of different stages in the gastric 
carcinogenesis sequence (for example IM versus dysplasia or dysplasia versus 
neoplasia), however, has not been evaluated in detail to date. The discrimination 
between different stages/types of gastric carcinogenesis is of particular clinical 
relevance, which may influence the decision of treatment strategies (e.g. ESD or 
surgery) for gastric patients. For instance, IM typically only requires HP eradication 
whereas endoscopic resection is more applicable to dysplastic lesions. Cancer on the 
other hand may require partial or full gastrectomy. Hence, the main aim of this 
chapter is to examine the capability of Raman endoscopy for the direct assessment of 
intestinal-type gastric carcinogenesis sequence in vivo during clinical endoscopic 
examination. 
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5.2 Materials and methods 
5.2.1 Raman instrumentation 
The Raman spectroscopy system used for in vivo tissue Raman measurements 
has been reported in detail in Section 4.2.1. 
5.2.2 Data processing 
The data processing has previously been reported in detail in Section 4.2.2. 
5.2.3 Study protocol 
The patient recruitment and ethical protocol has been reported in detail in 
Chapter 3. In this work, Raman data from 83 patients were analyzed including spectra 
from normal tissue (n=850), IM (n=71), dysplasia (n=92) and intestinal type 
adenocarcinoma (n=264). Tissue histopathology serves as the gold standard for 
evaluation of the performance of Raman technique for in vivo tissue diagnosis and 
characterization. 
5.2.4 Spectral modeling 
To assess the semi-quantitative differences between different tissue types in 
vivo, we have developed an on-line spectral modelling of the in vivo tissue Raman 
spectra using basis reference biochemical.
132
 The semi-quantitative spectral modeling 
technique has been described in Section 2.4.5 Statistical significance (p-values) was 
calculated using one-way ANOVA with Fisher post hoc least significant difference 
(LSD) test at the 0.05 level. 
5.2.5 Multi-class diagnostics 
To realize in vivo discrimination between different gastric tissue pathologies, the 
multi-class probabilistic PLS-DA is utilized as described in Section 2.4.3. Leave-one 
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patient-out cross-validation was used to assess PLS-DA model complexity. We 
further extend the dichotomous PLS-DA algorithm for multi-class classification using 
one-against-one scheme with max-wins voting.
82
 Thus, a total of 6 PLS-DA models 
were rendered (e.g. normal vs. IM; normal vs. dysplasia etc.) with varying 
complexities spanning from 1 to 3 LVs. Independent validation in this study was then 
performed by splitting the data-set into training (80% of dataset) and testing (20% 
of dataset). The split testing was performed on the patient basis ensuring independent 
validation.  
5.3 Results 
A total of 1277 in vivo tissue Raman spectra (normal gastric mucosa (n = 850), 
IM (n=71), dysplasia (n=92), intestinal-type adenocarcinoma (n=264)) were analyzed 
from 237 tissue sites of 83 gastric patients for gastric tissue diagnosis and 
characterization. Figure 5.1 shows the mean Raman spectra ±1 SD of normal gastric 
mucosa, IM, dysplasia and intestinal-type adenocarcinoma.  
 
Figure 5.1 Mean in vivo Raman spectra ±1 standard deviation (SD) of (a) normal mucosa; (b) 
intestinal metaplasia; (c) dysplasia, and (d) intestinal-type adenocarcinoma. Also shown are the 
corresponding Raman endoscopy procedures under white light reflectance (WLR) and narrow-
band imaging (NBI) guidance. 
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The corresponding images of the associated WLR/NBI guided Raman endoscopy 
procedures are also shown in Figure 5.1. The spectral differences (e.g. peak intensity 
and bandwidth) between different tissue types are subtle, but are consistent over most 
parts of the Raman spectra (p < 0.05). The prominent tissue Raman peaks (Table 1) 
are identified with tentative biomolecular assignments
27, 64, 97, 122
 as follows: 936 cm
-1 
(υ(C-C) proteins), 1004 cm-1 (υ(C–C) ring breathing of phenylalanine), 1078 cm-1 
(υ(C–C) of lipids), 1265 cm-1 (amide III υ(C–N) and (N–H) of proteins), 1302 cm-1 
(CH3CH2 twisting and wagging of proteins and lipids), 1445 cm
-1 ((CH2) 
deformation of proteins and lipids), 1655 cm
-1 (amide I υ(C=O) of proteins) and 1745 
cm
-1 (υ(C=O) of lipids). Figure 5.2 gives the representative hematoxylin and eosin (H 
& E) slides (×200 magnification) of the corresponding tissue sites in intestinal-type 
gastric carcinogenesis measured using Raman endoscopy, which include (a) normal 
oxyntic gastric mucosa; (b) extensive IM where the gastric epithelium contains 
apparent goblet cells; (c) low-grade dysplasia showing abnormal nuclear content and 
the associated intestinal metaplasia, and (d) intestinal-type gastric adenocarcinoma. 
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Figure 5.2 Photomicrographs of the haematoxylin and eosin (H&E)-stained sectioned slides 
(×200 magnifications) of gastric tissues: (a) normal oxyntic mucosa; (b) extensive intestinal 




Semi-quantitative spectral modelling was used to correlate spectral changes 
with the biomolecular and histopathological manifestations in gastric intestinal- type 
carcinogenesis (Figure 5.2). Figure 5.3a shows the measured Raman spectra of the 
dominant reference basis components (i.e. proteins, glycoprotein, DNA, lipids and 
blood) in gastric tissue. The measured tissue Raman spectra (black color) and 
reconstructed spectra (red color) (Figure 5.3b) agree well with each other (fit residuals 
of <10%), suggesting the important role of these biochemical components in gastric 
tissue. Figure 5.4a-e summarizes the relative spectral contributions ±1 SE in bar 
diagrams together with the corresponding p-values. The results show a gradual 
transformation from normal to IM, dysplasia and ultimately adenocarcinoma, 
reflecting the progressive accumulation of biomolecular and morphological changes 
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in the gastric tissue. Of particular significance, dysplastic and cancerous lesions 
showed progressive changes in DNA (p < 0.01), blood (p < 0.001) and lipid content. 
The above results demonstrate that Raman endoscopy can directly monitor the multi-
step gastric carcinogenesis sequence in vivo ranging from normal tissue, intestinal 
metaplasia, dysplasia and final progression into adenocarcinoma exclusively based on 
biomolecular manifestations. To exemplify it graphically, Figure 5.5a depicts a scatter 
plot of blood versus DNA content for normal + IM, dysplasia and adenocarcinoma, 
illustrating the diagnostic significance of nuclear abnormalities and neovasculation. 
Figure 5.5b shows the proteins versus lipids content for dysplastic and cancerous 
lesions, elucidating the distinct clustering between precancer and cancer tissue. Based 
on these specific endogenous biomolecules, neoplasia can be discriminated from 
dysplasia with a sensitivity of 76.73% and specificity of 61.96%. Overall, the above 
results substantiate that Raman endoscopy probes the intestinal-type gastric 
carcinogenesis sequence and can aid in objective histopathological assessments of 
gastric tissue in vivo based on the intrinsic biomolecular signatures. 
  
Figure 5.3 (a) The five basis reference Raman spectra from lipids, DNA, glycoprotein, proteins 
and blood used for Raman biomolecular modelling of carcinogenesis process. (b) Comparison of 
the measured in vivo gastric Raman spectra (black color) with the reconstructed tissue Raman 
spectra (red color) through Raman biomolecular modelling among different gastric tissue types 
(i.e. normal mucosa, intestinal metaplasia, dysplasia and adenocarcinoma). 
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To realize multi-class discrimination between different histopathological types, we 
rendered probabilistic PLS-DA algorithms for differentiation among the four gastric 
tissue types (i.e. normal, IM, dysplasia and adenocarcinoma) by splitting the dataset 
into training (80% of dataset) and testing (20% of dataset). Table 6 summarizes the 
probabilistic PLS-DA prediction results (i.e. sensitivity, specificity and accuracy) of 
the testing dataset in a confusion matrix. We found that normal mucosa could be 
detected with accuracy of 79.69%, (sensitivity: 75.88%; specificity: 87.21%). IM 
phenotype was identified with accuracy of 85.16% (sensitivity: 46.67%; specificity: 
87.55%), whereas dysplastic tissues were identified with accuracy of 94.92% 
(sensitivity: 83.33%; specificity: 95.80%) and adenocarcinoma with accuracy of 
93.36% (sensitivity: 84.91%; specificity: 95.57%). These findings suggest that 
besides resolving gastric intestinal-type carcinogenesis at the biomolecular level 
(Figure 5.4), Raman endoscopy can also be used for targeted biopsies of high-risk 
lesions as well as discrimination between precancer and cancer during clinical 





Figure 5.4 Bar histograms 1 standard error (SE) of the relative fit coefficients of (a) DNA; (b) 
mucin; (c) lipids; (d) proteins and (e) blood for the four different tissue types (i.e. normal mucosa, 




Figure 5.5 (a) Scatter plots of blood versus DNA contents for normal + IM, dysplasia and 






Table 6 Confusion matrix and diagnostics of 20% of the dataset (n=256 spectra) based on in vivo 
Raman spectroscopy and multi-class probabilistic partial least squares-discriminant analysis (PLS-
DA) together with one-against-one voting. 
 
5.4 Discussion 
The pathogenesis of intestinal-type gastric adenocarcinoma is a complex 
cascade process of biomolecular and morphological changes that include intermediate 
transformation to IM before development of dysplasia and the risk leading to invasive 
carcinoma (Figure 5.2).
138
 Identification of early predisposing lesions is very 
challenging during clinical endoscopic procedures. Thus, the development of a label-
free optical diagnostic technology that can interrogate the biomolecular information of 
tissue architecture and cytology in vivo would be of great clinical value at endoscopy. 
The distinction between normal, precancer and cancer in intestinal-type gastric 
carcinogenesis in this study is of highly clinical relevance, and could greatly reduce 
multiple redundant biopsies to tremendously benefit the gastric patients at high risk. 
This work is the first fiber-optic Raman endoscopic study to investigate the 
multi-step intestinal-type carcinogenesis sequence in vivo in the stomach time during 
clinical gastroscopy. The spectral modelling based on endogenous biomolecular 
components was able to derive semi-quantitative biomolecular information from the 
in vivo tissue Raman spectra with subtle fit residuals (of <10%), despite of the gross 
simplification without modelling of inter- and intra-molecular interactions, optical 
absorption and scattering properties of tissue, etc.
122
 Remarkably, Raman endoscopy 
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together with spectral modelling resolves the cascade of biomolecular events, and tis- 
sue Raman features identified correlate well with the histopathology of gastric 
carcinogenesis (Figure 5.2). In particular, we found that IM showed an increased 
content of DNA (p < 0.001) and proteins (p < 0.001) compared to normal mucosa. 
This observation is consistent with flow cytometric studies revealing DNA aneuploidy 
in IM that is characterized by an increased hyperproliferative activity of gastric 
epithelial cells.
140
 With the assumption that different mucin subtypes produce very 
subtle spectral differences,
23
 it is plausible that the overall mucin content can be 
reflected in the spectral modeling. The changes in glycoprotein content is likely 
caused by the transition to a glandular phenotype expressing goblet, paneths and 
absorptive cells for IM pathology that secrete mucins (i.e. sialomucins and 
sulfomucins)
27
 different from those secreted by the normal gastric foveolar cells (e.g. 
neutral mucin such as MUC5AC). The changes in glycoprotein associated with 
carcinogenesis (p < 0.05) could be explained with variations and losses in expression 
of distinct mucin subtypes (e.g. MUC2, MUC5AC, and MUC6). Neoplastic tissues 
were also highly associated with up-regulated DNA (p < 0.001) and proteins (p < 
0.01) contents in accordance with histopathological and cellular characterization 
(Figure 5.2). Overall, the semi-quantitative spectral modelling indicates a gradual 
disease transformation from normal, IM to dysplasia and ultimately adenocarcinoma 
that likely reflect a multitude of oncogenes, cell cycle regulators, growth factors (i.e. 
progressive accumulation of biochemical and biomolecular changes)
116, 137, 140-142
 
together with the changes in tissue architecture. In addition, we also observe a 
prominent reduction in lipid Raman signals in neoplastic tissue (p < 0.001) that is 
likely due to the thickening of mucosa and light absorption obscuring the Raman 
signals from deeper subcutaneous fat layers. Further, adenocarcinoma tissue shows 
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intense Raman peaks at 1004 cm
-1 (phenylalanine υs(C–C)), amide III (1265 cm
-1
) and 
amide I band (1655 cm
-1
) that are optical biomarkers related to increased protein con- 
tents. These results suggest the increased proliferation of cancer cells constituting the 
gastric tissue.
137
 The spectral modelling (Figure 5.4) also confirms that Raman 
spectroscopy resolves the gradual angiogenesis and resulting neovasculation 
processes of gastric carcinogenesis in vivo. Overall, in vivo Raman endoscopy in 
conjunction with semi-quantitative spectral modelling provides good agreement with 
histopathological characterization in gastric tissue in vivo at the molecular level. Our 
previous Raman studies
26-29
 showed that Raman endoscopy yielded a good diagnostic 
accuracy (>90%) for in vivo diagnosis of gastric dysplasia and neoplasia. In this work, 
our probabilistic PLS-DA multi-class analysis discloses that Raman endoscopy can be 
further used for targeted biopsies and discrimination between dysplastic and 
neoplastic lesions (Figure 5.5a). The finding reconfirms the capability of fiber-optic 
Raman spectroscopy to directly assess the depth of invasion of lesions occurring 
either in the epithelium tissue or bulky malignant lesions. Misclassifications in Table 
6 are likely caused by the diffuse histopathological borderline between high-grade 
dysplasia and cancer that might be partially solved with consensus pathology. On the 
other hand, the sensitivity of detecting IM was rather poor, which may be due to the 
reason that this volume-type Raman probe interrogates with gastric tissue of up to 800 
µm in depth, diluting the subsurface (IM) tissue Raman signal with deeper bulky 
tissue Raman. The current volume-type Raman probe design may not be efficient for 
selectively targeting IM that is largely confined to the epithelium. With the 
development of the second generation of confocal Raman probe designs for depth-
resolved measurements currently under testing in the Optical Bioimaging Laboratory 
at NUS, the confocal Raman spectroscopy is expected to increase the detection 
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sensitivity for both IM and early dysplasia by selectively measuring tissue signals 
from the epithelium. Nevertheless, the biomolecular spectral modeling on in vivo 
Raman spectra in this work gives rise to statistical significant differences in the 
Raman spectra among IM phenotype and normal mucosa. In vivo Raman endoscopy 
reveals the specific endogenous biomolecules (i.e. optical biomarkers) responsible for 
the progression of intestinal-type gastric carcinogenesis in situ. Raman endoscopic 
technique can discriminate between normal mucosa, dysplasia and invasive cancer 
with high biomolecular specificity. Diagnostic accuracies of 80 – 95% are adequate to 
guide the targeted biopsy of suspicious lesions, thereby reducing the number of 
negative biopsies. For instance, dysplastic cell can eventually appear within areas of 
IM. As dysplastic foci are prone to sampling errors during endoscopy, Raman 
spectroscopy can benefit by accurately identifying these high-risk lesions for targeted 
biopsies. One notes that the current in vivo gastric tissue Raman datasets acquired are 
unbalanced with a relatively larger number of true negatives but a smaller pathologic 
tissue (e.g. IM, dysplasia), which may give rise to a biased overall accuracy within the 
PLS-DA models. Currently, clinical Raman measurements on a larger series of gastric 
patients to obtain balanced numbers of different pathologic groups are in progress in 
the Endoscope Centre at NUH for further evaluating the true clinical merits of Raman 
endoscopic technique for improving the early diagnosis of gastric precancer and 
cancer during endoscopic examination. 
5.5 Conclusion 
This chapter assessed the capability of Raman spectroscopy for multi-class 
elucidation of intestinal-type gastric carcinogenesis sequence in vivo for improving 
precancer detection at endoscopy. We employ the novel image-guided Raman 
endoscopy technique developed for in vivo gastric tissue Raman measurement within 
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0.5 s during clinical endoscopic examination. In vivo Raman spectroscopy integrated 
with semi-quantitative spectral modeling (e.g. DNA, lipids, glycoprotein, proteins and 
blood) reveals the progressive changes of biochemical constituents in gastric tissue 
associated with preneoplastic and neoplastic transformation (i.e., IM, dysplasia and 
adenocarcinoma). In this chapter we demonstrate that Raman spectroscopy is a 
sensitive biomolecular probe for monitoring intestinal-type gastric carcinogenesis to 
realize early diagnosis and detection of precancer and early gastric cancer in vivo 




Chapter 6. Development of a real-time framework for in vivo, 
on-line diagnosis during clinical endoscopic examination 
Data analysis of tissue Raman spectra in the literature has mostly been limited to 
post-processing and off-line algorithm development. In this Chapter, a comprehensive 
automated on-line Raman spectral diagnostics framework is developed to realize real-
time prospective in vivo cancer detection at endoscopy. A total of 2748 in vivo gastric 
tissue spectra (2465 normal and 283 cancer) were used from 305 patients recruited to 
construct a spectral database for diagnostic algorithms development. The novel 
diagnostic scheme developed implements on-line preprocessing, outlier detection 
based on principal component analysis statistics (i.e., Hotelling‟s T2 and Q-residuals) 
for tissue Raman spectra verification as well as probabilistic multivariate diagnostics. 
Free-running optical diagnosis with multivariate/chemometric processing times of < 
0.13 s can be achieved, which is important to realizing real-time in vivo tissue 
diagnostics during clinical endoscopic examination. The optimized partial least 
squares-discriminant analysis (PLS-DA) models based on the randomly resampled 
training database (80% for learning and 20% for testing) provide the diagnostic 
accuracy of 85.6% (95% confidence interval (CI): 82.9% to 88.2%) (sensitivity of 
80.5% (95% CI: 71.4% to 89.6%) and specificity of 86.2% (95% CI: 83.6% to 
88.7%)) for the detection of gastric cancer. The PLS-DA algorithms are further 
applied prospectively for the first time on 10 gastric patients at gastroscopy, achieving 
the predictive accuracy of 80.0% (60∕75) (sensitivity of 90.0% (27∕30) and specificity 
of 73.3% (33∕45)) for in vivo diagnosis of gastric cancer. This chapter successfully 
moves biomedical Raman spectroscopic technique into real-time, on-line prospective 





Few groups have reported on the implementation of real-time tissue Raman 
spectroscopy.
143
 Feld et al. presented a synchronized laser Raman system that could 
acquire and process Raman spectra within 2 s using spectral modeling of reference 
biochemicals with an aid of least squares regression techniques.
93, 144-148
 Zeng et al. 
developed a real-time integrated Raman system for evaluating skin that could acquire 
and process the signal within 1.1 s.
143
 Nevertheless, most of the current Raman 
spectroscopic analyses have been limited to off-line post processing for classification 
of spectra with cross-validation procedures, which render practical limitations 
including the setting of exposure times, post-verification of spectrum quality, and lack 
of automatic feedback mechanisms to the clinicians for implementation of straight-
forward probabilistic diagnostics in clinical settings. Fully automated tissue spectral 
quality verification and real-time tissue cancer diagnostics are vital to translating the 
Raman spectroscopic diagnostic technique into prospective clinical endoscopic 
routine. In this work, we develop an on-line biomedical spectral diagnostic framework 
integrated with the novel image-guided Raman endoscopy for real-time probabilistic 
detection of cancer in the upper GI. We also validate the efficacy of the on-line 
Raman framework developed for prospective real-time prediction in patients with 
gastric malignancies at clinical endoscopy. 
6.2 Materials and methods 
 
6.2.1 Raman instrumentation 
The Raman spectroscopy system used for in vivo tissue Raman measurements has 
been reported in detail in Chapter 4.2.1. 
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6.2.2 Study protocol 
The ethical protocol has been reported in Chapter 3. In this work, a total of 
2748 in vivo gastric tissue spectra (normal (n=2465) and cancer (n=283)) from the 
305 patients were used to construct the spectral database for developing diagnostic 
algorithms for gastric cancer diagnostics. Tissue histopathology serves as the gold 
standard for evaluation of the performance of Raman technique for in vivo tissue 
diagnosis and characterization. 
6.2.3 Development of on-line Raman spectroscopic 
framework 
The on-line biomedical Raman spectroscopic framework developed has been 
implemented as a graphical user interface (GUI) under the Matlab 2011a (Mathworks 
Inc., Natick, MA) scripting environment in a fast computing workstation (64 bit I7 
quad-core 4GB memory). This framework has been thoroughly optimized for rapid 
data processing for real-time tissue diagnostics. Hardware components of the rapid 
Raman system (e.g., laser power control, spectrometer, CCD shutter and camera 
readout synchronization) have been interfaced to the Matlab software through 
libraries for different spectrometers/cameras (e.g., PVCAM library (Princeton 
Instruments, Roper Scientific, Inc., Trenton, NJ) and Omni Driver (Ocean Optics Inc., 
Dune- din, FL), etc.). A schematic of the spectral acquisition and processing flow of 
on-line diagnostic framework is depicted in Figure 6.1. The laser was electronically 
synchronized with the CCD shutter. The automatic adjustment of laser power, 
exposure time and accumulation of spectra were realized by scaling to within 85% of 
the total photon counts (e.g., 55,250 of 65,000 photons) based on preceding tissue 
Raman measurements, whereas an upper limit of 0.5 s was set to realize clinically 
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acceptable conditions. The accumulation of multiple spectra and automatic adjustment 
of exposure time provides a rapid and straightforward methodology to prevent CCD 
saturation and to obtain high signal-to-noise ratios (SNR) for endoscopic applications. 
The Raman-shift axis (wavelength) was calibrated using a mercury/argon calibration 
lamp (Ocean Optics Inc., Dunedin, FL). The spectral response correction for the 
wavelength-dependence of the system was conducted using a standard lamp (RS-10, 
EG&G Gamma Scientific, San Diego, CA). The reproducibility of the platform can be 
continuously monitored with the laser frequency and Raman spectra of cyclohexane 
and acetaminophen as wavenumber standards. All the system performance measures 
including CCD temperature, integration time, laser power, CCD alignment are 
accordingly logged into a central database via SQL server. Due to the inter-
anatomical and inter-organ spectral variances as we observed (Chapter 4), the on-line 
framework we designed implements organ-specific diagnostic models in a database 
structure and can instantly switch among the spectral databases of different organs 
(e.g., esophagus, gastric, colon, cervix, bladder, lung, nasopharynx, larynx, and the 
oral cavity (hard palate, soft palate, buccal, inner lip, ventral and the tongue)), making 
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6.2.1 On-line preprocessing and outlier detection 
Real-time preprocessing of Raman signals was realized with the detection of 
cosmic rays using the first derivative with a 95% or 99% CI over the whole spectral 
range set as a maximum threshold. Data points lying outside of a threshold were 
interpolated to 2
nd
 order. The spectra were further scaled with integration time and 
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laser power. A Savitzky-Golay smoothing filter was used to remove noise in the 
intensity corrected spectra, while a fifth order modified polynomial constrained to the 
lower bound of smoothed spectra was subtracted to resolve the tissue Raman 
spectrum alone.
25, 77, 117
 The Raman spectra were further normalized to the integrated 
area under the curve, enabling a better comparison of the spectral shapes and relative 
Raman band intensities among different tissue pathologies. The spectra were then 
locally mean-centered according to the specific database to remove common 
variations in the data. Following preprocessing, the Raman spectra were fed to a 
model-specific outlier analysis.  
We incorporate an on-line outlier detection scheme into biomedical 
spectroscopy as a high-level model-specific feedback tool in our on-line framework 
by using PCA coupled with Hotelling‟s T2 and Q-residual statistics.149, 150 Briefly, 
PCA reduces the dimension of the Raman spectra by decomposing them into linear 
combinations of orthogonal PCs, such that the spectral variations in the dataset are 
maximized. The PCA model is defined by Equation [4]:
151
 Accordingly, Hotelling‟s T2 
statistics is a measure of variance captured by the PCA model (sample to model 
distance) and is defined by:
149
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 is used as a weighting factor for the PCs contributing with different variances. 
Therefore, Hotelling‟s T2 gives an indication of extreme values within the PCA model. 
On the other hand, Q-residuals is a measure of variance which is not captured by the 
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where xi is the sample spectrum, Qik is the sum of squared reconstruction error for i
th
 
sample spectrum using component k and Pk is the PC loading vectors. For both 
Hotelling‟s T2 and Q-residuals, the normalized 99% CI was utilized as upper 
thresholds to intercept anomalous Raman spectra (e.g., non-contact measurements, 
spectra from blood, etc.) Accordingly, the Hotelling‟s T2 and Q-residuals are two 
independent parameters providing quantitative information about the model fit. Using 
these parameters as indicators of spectrum quality (i.e., probe contact mode, 
confounding factors, white light interference, etc.), auditory feedback has been 
integrated into the on-line Raman diagnostic system, facilitating real-time probe 
handling advice and spectroscopic screening for clinicians during clinical endoscopy 
procedures. 
 
6.2.2 On-line probabilistic diagnostics 
Subsequent to outlier analysis of tissue Raman spectra quality, those qualified 
Raman spectra are immediately fed to probabilistic models for on-line in vivo 
diagnostics and pathology prediction. The GUI can instantly switch among different 
models including PLS-DA, PCA-LDA, ACO-LDA, CART, SVM, adaptive boosting 
(Ada-Boost), etc. for prospective classification at clinical endoscopic procedures. In 
this study, as an example, probabilistic PLS-DA was employed for gastric cancer 
diagnosis. The developed system also supports binary classification, one-against-all 
and one-against-one multiclass (i.e., benign, dysplasia, and cancer) probabilistic PLS-
DA discriminatory analysis to predict the specific tissue pathologies. 
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Figure 6.2 shows the developed GUI for on-line biomedical spectroscopic 
processing and diagnostics. We tested the developed on-line framework in the 
stomach that represents one of the most challenging organs presenting with many 
confounding factors (i.e., gastric juice, food debris, bleeding, exudates, etc.) for 
spectroscopic diagnosis. The in vivo mean Raman spectra acquired from 305 gastric 
patients (normal (n = 2465) and cancer (n = 283)) for algorithms development are 
shown in Figure 6.3. A detailed analysis and discussion of the Raman spectral 
characteristics of carcinogenesis in the gastric was presented in Chapter 5. 
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Figure 6.3 In vivo mean Raman spectra of normal (n = 2465) and cancer (n = 283) gastric tissue 
acquired from 305 gastric patients. 
 
The automatic outlier detection was realized for predictive on-line analysis using PCA 
with Hotelling‟s T2 and Q-residuals statistics (99% CI). A two-component PCA 
model was rendered that included the largest tissue spectral variations. These selected 
significant PCs (p < 0.0001) accounted for maximum variance of 38.71% (PC1: 
30.33%, PC2: 8.38%) of the total variability in the dataset (n = 2748 Raman spectra), 
and the corresponding PC loadings are shown in Figure 6.4 . 
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Figure 6.4 The principal component (PC) loadings calculated from the spectral training database 
of 2748 (2465 normal and 283 cancer) Raman spectra of gastric tissue in vivo. The significant PCs 
capture a total variance of 38.71% (PC1, 30.33%; PC2, 8.38%). 
 
 
Figure 6.5  shows the score scatter plots (i.e., PC1 versus PC2) for the normal (n = 
2465) and cancer tissue spectra (n = 283), exemplifying the capability of PC scores 
for separating the cancer spectra from normal. The 99% CI of Hotelling‟s T2 and Q 
residuals were accordingly calculated from the training dataset and fixed as a 
threshold for prospective on-line spectral validation.  
We then rendered probabilistic PLS-DA models for prediction of gastric 
cancer. The training database was randomly resampled multiple times (n = 10) into 
learning (80%) and test (20%) sets. The generated PLS-DA models provided a 
predictive accuracy of 85.6% (95% CI: 82.9% to 88.2%) (sensitivity of 80.5% (95% 
CI: 71.4% to 89.6%) and specificity of 86.2% (95% CI: 83.6% to 88.7%)) for gastric 
cancer diagnosis. We subsequently tested the online framework (i.e., outlier-detection 
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as well as probabilistic PLS-DA) in 10 prospective gastric patients. PC score scatter 
plots (i.e., PC1 versus PC2) for the prospective normal (n = 45) and cancer (n = 30) 
tissue spectra are also shown in Figure 6.5. 
 
Figure 6.5 Scatter plots of the two diagnostically significant PC scores (PC1 versus PC2) with a 
total variance of 38.71% (PCl, 30.33%; PC2, 8.38%) for 2465 normal (training database) and 283 
cancer (training database) gastric tissue Raman spectra, together with the PC scores of prospective 
45 normal and 30 gastric cancer Raman spectra. 
 
 
Figure 6.6 shows the prospective scatter plot of the Hotelling‟s T2 (38.71%) and Q-
residuals (61.29%) with the 99% CI boundaries for 105 spectra acquired from the 
prospective gastric patients. It is observed that a large number of noncontact spectra 
lie outside the 99% CI and are therefore discarded in real-time. The verified tissue 
Raman spectra largely fall inside the 99% CI of T
2
 and Q residuals, demonstrating 
that this on-line data analysis provides a rapid and highly efficient means of real-time 
validation of biomedical tissue spectra. The prospectively acquired spectra verified by 
the on-line outlier analysis are further fed to probabilistic PLS-DA for instant disease 
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prediction, achieving a diagnostic accuracy of 80.0% (60∕75) (sensitivity of 90.0% 
(27∕30), and specificity of 73.3% (33∕45)) for gastric cancer detection (Figure 6.7 ), as 
confirmed by histopathological examination. 
 
Figure 6.6 Hotelling‟s T
2
 versus Q-residuals for 105 Raman spectra (45 normal, 30 cancer, 30 
outlier) acquired from 10 prospective gastric samples. The outlier (n = 30 green triangles) shows 
higher T
2 and higher Q values than the valid spectra. The dotted line represents the 99% 
confidence interval (CI) verifying whether the prospective Raman spectra are within the common 




Figure 6.7 Scatter plot of the posterior probability values belonging to prospective normal (n = 
45) and cancer (n = 30) gastric tissue based on PLS-DA modeling. The separate dotted line gives a 
diagnostic sensitivity of 90.0% (27∕30) and specificity of 73.3% (33∕45) for separating cancer from 
normal gastric tissue in vivo. 
 
 
The ROC curves were further generated to evaluate the group separations. Figure 6.8  
shows the mean of the ROC curves computed from each random splitting of the 
spectral database for retrospective prediction as well as the ROC calculated for the 
prospective dataset prediction. The integration areas under the ROC curves generated 
for the retrospective and prospective datasets are 0.90 and 0.92, respectively, 
illustrating the robustness of the PLS-DA algorithm for prospective gastric cancer 




Figure 6.8 The ROC curves computed from the spectral database for retrospective prediction as 
well as ROC curve for prospective prediction of normal and cancer gastric tissue. The integrated 
areas under the ROC curves are 0.90 and 0.92 for the retrospective and prospective datasets, 
respectively, illustrating the efficacy of Raman endoscopy together with PLS-DA algorithms for 
in vivo gastric cancer diagnosis. 
 
The total processing time for the framework was 0.13 s. The processing time for each 
step of the flow chart (Figure 6.1) are given in Table 7. Free-running optical diagnosis 
and processing time of < 0.13 s can be achieved, which is critical for realizing real-
time in vivo tissue diagnostics at endoscopy. Overall, this work demonstrates for the 
first time that the on-line biomedical diagnostic framework can move the biomedical 
Raman spectroscopy into real-time, on-line cancer detection and diagnosis during 




Table 7 Average processing time for on-line biomedical Raman spectroscopic framework on a 
personal computer with a 64-bit I7 quad-core 4GB memory. 
 
6.2 Discussion 
We have presented an on-line framework for biomedical Raman spectroscopy 
that integrates preprocessing, automatic outlier detection, and deploys instant change 
of diagnostic models among different organs in the upper GI tract during gastroscopy. 
We have introduced automated outlier detection for spectra verification in endoscopic 
applications. PCA with related Hotelling‟s T2 and Q-residuals is a high-level metrics 
for outlier detection, and we found that it is highly efficient and reliable in our on-line 
diagnostic platform at endoscopic diagnosis. The PCA model was generated from the 
database accounting for the majority of common tissue variations (38.71% of total 
variance, PC1: 30.33%; PC2: 8.38%) (Figure 6.4 ). The rendered PCA model was 
further tested prospectively on 10 gastric patients for prospective automatic outlier 
detection during in vivo on-line Raman spectroscopic screening (Figure 6.6). Of the 
total 105 gastric spectra acquired from the prospective gastric patients, 75 spectra that 
fit the developed PCA model well (T
2 and Q lies within 99% CI (blue and red 
circles)) were eligible for further classification. The remaining spectra (green 
triangles) from noncontact measurements, food debris or blood contaminations show 
unusual disturbances, which were poorly reconstructed by the PCA model. Large Q-
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residuals indicated the presence of spectral variations unexplainable by the model due 
to many confounding factors (e.g., noncontact mode, contaminants, or unknown 
spectral variations) frequently occurring in in vivo clinical measurements. One noted 
that tissue Raman spectra presenting with Q-residuals vaguely outside the CI ((n = 6) 
were accepted following off-line analysis because the newly introduced spectral 
variations could be due to tumor invasion, necrosis, tumor subtype, etc. Thus 
following on-line analysis, it is advisable to review the spectra in off-line mode to 
assess possible new spectral variations. This study thoroughly shows the necessity of 
utilizing automated outlier diagnostics for tissue Raman spectral quality verification 
in real-time endoscopic applications. 
Subsequent to on-line outlier analysis, the spectra were fed to probabilistic PLS-
DA algorithms for disease prediction. The PLS-DA modeling provided the predictive 
accuracy of 80.0% (60∕75) (sensitivity of 90.0% (27∕30) and specificity of 73.3% 
(33∕45)) (Figure 6.7 ) for cancer diagnosis on 10 prospective gastric patients, 
suggesting that Raman endoscopy with the integration of on-line diagnostic 
framework can be a diagnostic screening tool for real-time in vivo gastric cancer 
identification. These probabilistic diagnostic outcomes were presented in real-time to 
the endoscopists within 0.13 s, which is a clinically acceptable time at endoscopy. 
With the immediate auditory diagnostic feedback from the GUI developed, the 
endoscopists can now perform point-wise scanning for targeted biopsies of the high-
risk tissue sites. The movie (Supplementary information: 
http://biomedicaloptics.spiedigitallibrary.org/article.aspx?articleid=1352558) shows 
the on-line Raman endoscopic diagnostic procedure for real-time in vivo detection of 
gastric cancer during clinical endoscopic examination. 
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6.1 Conclusion 
In this chapter, we have developed an on-line biomedical Raman spectroscopic 
framework to translate the cumbersome processing and multivariate/chemometric 
analysis into an easy-to-use GUI interface for real-time, in vivo prospective diagnosis 
of malignancies in the GI tract. The efficacy of the on-line diagnostic framework 
integrated with the multimodal image-guided clinical Raman spectroscopy was 
proven for the first time on the prospective gastric patients. 
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Chapter 7. Fiber-optic confocal Raman spectroscopy for 
real-time in vivo diagnosis of dysplasia in Barrett's 
esophagus 
In this chapter we apply the developed on-line Raman technique prospectively 
in the BE esophagus. BE is a condition that poses high risk of developing dysplasia 
leading to esophageal adenocarcinoma. Early detection of dysplasia in BE is critical 
but remains endoscopically challenging. The current diagnostic approaches for 
detecting BE relies on random biopsy sampling guidelines, resulting in a vast number 
of negative biopsies. To improve the sensitivity of Raman technique for precancerous 
lesions, we develop a novel fiber-optic confocal Raman spectroscopy technique. We 
acquire a spectral reference database of 373 patients and demonstrate the prospective 
diagnostics in 77 patients in vivo during clinical endoscopy. High-quality epithelial 
Raman spectra can be acquired from esophagus in vivo and processed in real-time 
(<0.5 second). Confocal Raman spectra show significantly spectral differences (p < 
0.001) among different esophageal tissue types (i.e., columnar lined, non-dysplastic 
BE, and dysplastic BE). Fiber-optic confocal Raman spectroscopy provides a 
diagnostic sensitivity of 87.0% (67/77) and a specificity of 84.7% (610/720) for in 
vivo detection of dysplasia in 77 patients prospectively based on endogenous 
biomolecular signatures. This chapter demonstrates for the first time that the real-time 
fiber-optic confocal Raman spectroscopy can be used to prospectively detect 





7.1 Introduction  
BE is a metaplastic precursor of EAC. Since the late 1970s, EAC has had a 
substantial rise in incidence rates (>350%), and is growing more rapidly than other 
cancers in the developed countries, despite of extensive efforts for prevention, 
including periodic surveillance of high-risk BE patients.
13, 14
 The incidence of EAC is 
continuously increasing and the five-year survival rates remain low. Given the poor 
therapeutic response of symptomatic EAC, early identification of high-risk lesions 
(i.e., dysplasia) together with therapeutic interventions are currently the most critical 
measures to improving survival rates of BE patients.
13, 14
 However, dysplastic lesions 
or grossly inconspicuous cancers can be endoscopically indistinguishable from the 
surrounding metaplastic tissue. This is because conventional endoscopy heavily relies 
on visual assessment of structural and morphological features of tissue surface, 
resulting in poor diagnostic accuracy. Existing diagnostic guidelines recommend 
extensive biopsy samplings (typically four-quadrant samplings) at every 1-2 cm 
interval along suspicious Barrett‟s segments during endoscopic inspections of BE 
patients. This approach produces a vast number of negative biopsies, and is clinically 
labor intensive and a burden to the patients. Since only a minute amount of the 
mucosa is sampled (as little as 5%), tissue biopsies do not accurately characterize BE 
segments. Foci of dysplasia in a background of IM are frequently overlooked even 
when the biopsies are diligently performed by experienced endoscopists using 
extensive four-quadrant biopsy protocols. Taken into account the enormous rise in 
incidence of EAC and the existing clinical challenges, the need for new advanced 
endoscopic modalities has never been greater. The objective targeting of high-risk 
tissue areas with a minimally invasive technique could greatly reduce random biopsy 
sampling errors as well as health care expenses and burden on the patients. In 2004, 
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Motz et al. presented a 2 mm diameter sapphire ball lens coupled fiber-optic probe.
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In this report, we present the first in vivo application of a fiber-optic confocal Raman 
spectroscopy technique for real-time prospective diagnosis of dysplasia in BE at 
endoscopy. 
 
7.2 Materials and methods 
7.2.1 Fiber-optic confocal Raman instrumentation  
The developed fiber-optic confocal Raman spectroscopic system (Figure 7.1) 
consists of a NIR diode laser (ex = 785 nm), a high-throughput transmissive imaging 
spectrograph equipped with a liquid nitrogen-cooled, NIR-optimized CCD camera 
and a specially designed 1.8-mm (in outer diameter) fiber-optic confocal Raman 
probe.
125
 The system acquires Raman spectra in the range of 800-1800 cm
-1
 with a 
spectral resolution of 9 cm-1. The developed fiber-optic confocal Raman endoscopic 
probe is used for both laser light delivery and in vivo tissue Raman signal collection.
6
 
The 1.8 mm confocal Raman endoscopic probe comprises 9 200 m filter-coated 
collection fibers (NA = 0.22) surrounding the central light delivery fiber (200 m in 
diameter, NA = 0.22). A miniature 1.0 mm sapphire ball lens (NA = 1.78) is coupled 
to the fiber tip of the confocal probe to tightly focus the excitation light onto tissue, 
enabling the effective Raman spectrum collection from the epithelial lining (< 200 
m).125 The fiber-optic confocal Raman probe can be inserted into the instrument 
channel of conventional endoscopes and placed in gentle contact with the epithelium 
for in vivo tissue characterization and diagnosis.  
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Figure 7.1 The rapid fiber-optic confocal Raman spectroscopy system developed for in vivo tissue 
diagnosis and characterization at endoscopy. 
 
The depth-selectivity of this probe with different bevelled angles of the 
collection fibers gives the instrument confocal properties (Figure 7.2)  which offers 
compelling experimental advantages,
125
 including (i) fiber-optic confocal Raman 
spectroscopy selectively targets the epithelial lining associated with early onset of 
Barrett‟s carcinogenesis which is superior to conventional volume-type fiber-optic 
Raman probes that interrogate a larger tissue volume; (ii) the shallower tissue 
interrogation ability of confocal Raman technique suppress tissue autofluorescence 
contribution and interferences from deeper tissue layers (e.g., stroma),
125 
(iii) confocal  
Raman technique enables more reproducible measurements (i.e., Raman signal is only 





Figure 7.2 Monte Carlo simulations: Normalized Raman photons collected as a function of tissue 
depths using different beveled fiber confocal Raman probes (β = 0°, 10°, and 20°; gap d = 0 μm) 







Figure 7.3 WLR and NBI image of a patient with Barrett‟s esophagus. The tongues of salmon 
appearing mucosa extending into the esophagus are associated with increased risk of developing 
esophageal adenocarcinoma. The images were obtained from Endoscopy Center, National 
University Hospital of Singapore (NUHS) with permission. 
 
 
7.2.1 Data processing 
The data processing has been reported in detail in Section 4.2.2  
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7.2.2 Study protocol 
The patient recruitment and ethical protocol has been reported in detail in 
Chapter 3. Biopsies are classified into the categories: Columnar-lined epithelium 
(CLE), nondysplastic BE defined as the presence of goblet cells, BE indeterminate for 
dysplasia, BE positive for low-grade dysplasia, and BE positive for HGD. The 
histopathology results (the gold standard) are compared with Raman measurements to 
determine the diagnostic performance of the confocal Raman technique for 
identifying dysplasia in BE. 
 
7.3 Results and discussion 
Figure 7.4 shows the mean in vivo confocal Raman spectra measured from the 
database of 373 patients presenting with different tissue types (CLE, n=907; 
nondysplastic BE, n=318; BE positive for HGD, n=177) as confirmed by 
histopathologic characterization. Prominent tissue Raman peaks are observed at 936 
cm
-1
 (υ(C-C) proteins), 1004 cm-1 (υs(C-C) ring breathing of phenylalanine), 1078 cm
-
1
 (υ(C-C) of lipids), 1265 cm-1 (amide III υ(C-N) and δ(N-H) of proteins), 1302 cm-1 
(CH2 twisting and wagging of lipids), 1445 cm
-1
 (δ(CH2) deformation of proteins and 
lipids), 1618 cm
-1 
(v(C=C) of porphyrins), 1655 cm
-1
 (amide I υ(C=O) of proteins), 
and 1745 cm
-1
 (υ(C=O) of lipids) (Table 1).25, 94, 125 Raman spectral differences (e.g., 
peak intensity, shifting, and band
 
broadening) can be discerned among different tissue 
types
 
(p < 0.001, unpaired 2-sided Student‟s t-test). While histopathology (Figure 7.5 
R) identifies the presence of
 
intestinal mucosa marked by goblet cells in nondysplastic 
BE as well as progressive architectural and cytologic atypia in dysplastic BE, the 
fiberoptic confocal Raman spectroscopy uncovers the biochemical and biomolecular
 
changes occurring in the epithelium accompanying
 Barrett‟s carcinogenesis. For 
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instance, the Barrett‟s tissue areas with pathologically confirmed HGD showed 
significant increased Raman intensities at 1004 cm
-1
 (phenylalanine) and 1655 cm
-1
 
(amide I of proteins; p < 0.001, unpaired 2-sided Student‟s t-test) compared with 
nondysplastic BE owing to up-regulated proteins content associated with an increased 
proliferation of epithelial cells in dysplastic BE.
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 The distinct Raman peaks such as 
1335 and 1576 cm
-1
 (Table 1) of DNA are also closely linked with nuclei 
abnormalities in dysplastic tissue and cells (Figure 7.5 R). One notes that the Raman 
biomolecular signature of CLE is distinct, but the nondysplastic BE bears a 
resemblance to that of dysplastic BE to a high degree, suggesting that transformation 
to IM phenotype is accompanied with prominent molecular abnormalities, which 
could be a key event in Barrett‟s carcinogenesis. Overall, the highly specific Raman 
molecular signatures observed reflect a multitude of endogenous optical biomarkers 
(e.g., oncoproteins, DNA content, mucin expression) in epithelial tissue.
91
 The 
correlation of the epithelial Raman spectral signatures with histopathology and 
histochemistry can deepen the understanding of Barrett‟s onset and progression in situ 
at the molecular level. 
94 
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Figure 7.4 The mean in vivo confocal Raman spectra of columnar-lined epithelium (n=907), 
intestinal metaplasia (n=318), dysplasia (n=177) acquired from 373 patients during clinical 
endoscopic examination. Each Raman spectrum is acquired within 0.1 to 0.5 sec. The spectra have 
been normalized to the Raman peak at 1445 cm
-1
 for comparison purpose. 
 
 
Figure 7.5 Representative hematoxylin and eosin (H&E)-stained histopathologic slides 
corresponding to different esophageal tissue types measured. (a) Squamous-lined epithelium, and 
(b) Columnar lined esophagus with absence of goblet cells (original magnification, 200×). (c) 
Nondysplastic Barrett‟s esophagus, where the normal stratified squamous epithelium is replaced 
by intestinal metaplastic (IM) epithelium containing goblet cells (original magnification, 200×). 
(d) High-grade dysplasia in Barrett‟s esophagus showing both architectural and cytologic atypia as 
well as crowded crypts with branching and papillary formation, cytologic pleomorphism and loss 
of polarity (original magnification, 100×). 
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Capitalizing on the rich epithelial Raman signatures acquired from 373 
patients, we have applied the confocal Raman spectroscopy technique together with 
multivariate diagnostic algorithms developed for in vivo prediction and diagnosis of 
prospective patients with suspicious BE. Figure 7.6 shows the 2-dimensional ternary 
plot of the posterior probabilities using trichotomous probabilistic PLS-DA on 77 
prospective patients belonging to (i) CLE (n=597), (ii) nondysplastic BE (n=123), and 
(iii) HGD BE (n=77), respectively, using confocal Raman spectroscopy technique. 
The corresponding receiver operating characteristic (ROC) curves of dichotomous 
discriminations among CLE versus nondysplastic BE + HGD BE, nondysplastic BE 
versus CLE + HGD BE, and HGD BE versus CLE + nondysplastic BE are shown in 
Figure 7.7, with the areas under ROC curves of being 0.88, 0.84, and 0.90, 
respectively, for different tissue classification. The ROC shows that fiber-optic 
confocal Raman spectroscopy provides a diagnostic sensitivity of 87.0% (67/77), and 
a specificity of 84.7% (610/720) for in vivo detection of HGD in BE. In the light of 
these promising prospective results, fiber-optic confocal Raman spectroscopy 
represents a potent optical diagnostic means to revealing the detailed endogenous 
biomolecular information of epithelial tissue, thereby enabling in vivo objective 
diagnosis of dysplasia in BE patients.  
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Figure 7.6 Two-dimensional ternary plot of the posterior probabilities of prospective 77 patients 
belonging to columnar-lined epithelium (CLE; n=597), nondysplastic Barrett‟s esophagus (BE; n 




Figure 7.7 Receiver operating characteristic (ROC) curves of dichotomous discriminations among 
CLE versus nondysplastic BE + HGD BE, nondysplastic BE versus CLE + HGD BE, and HGD 
BE versus CLE + nondysplastic BE, with the areas under ROC curves (AUC) of being 0.88, 0.84, 





7.4 Video Descriptions 
We demonstrated the clinical utility of fiber-optic confocal Raman spectroscopy 
for guiding the biopsies of suspicious BE at endoscopy (Supplemental Video, 
http://www.gastrojournal.org/article/S0016-5085%2813%2901585-0/addOns). A 54-
year-old Chinese man was scoped on the upper GI with conventional white-light 
reflectance (WLR) endoscopy and subsequently narrow-band imaging (NBI). Using 
WLR endoscopy, the suspicious Barrett‟s segment appeared salmon-colored with a 
tongue of columnar lined epithelium or BE extending approximately 2 cm into the 
esophagus. Under NBI, the adjacent normal squamous epithelium seemed greenish in 
color. There was no evidence of morphologic/structural or microvascular changes in 
the suspicious Barrett‟s segment to indicate the presence of dysplasia. After 
preliminary visualization under WLR/NBI, fiber-optic confocal Raman scans were 
performed on the suspicious Barrett‟s tongues. Confocal Raman spectral diagnosis 
was given in real-time (<0.2-0.5 sec) with auditory feedback, which identified the 
suspicious segment as a “low-risk” lesion corresponding to nondysplastic BE. 
Subsequent biopsies and histopathologic examinations confirmed that the measured 
tissue areas indeed were nondysplastic in nature, but with moderate to extensive 
presence of goblet cells.  
This study demonstrates for the first time that fiberoptic confocal Raman 
spectroscopy can be used to target dysplasia in BE patients in real-time. By enabling 
functional and biomolecular assessment, fiberoptic confocal Raman spectroscopy 
constitutes a new endoscopic modality for in vivo tissue diagnosis and 
characterization. The introduction of the objective diagnostic modality such as this 
could have a major impact on current endoscopic practice and clinical decision 
making. The use of fiberoptic confocal Raman spectroscopy may include many 
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clinical scenarios that require histopathologic biopsy samplings in screening of 
patients at higher risk of developing EAC. Ultimately, the targeting of dysplastic 
lesions and the discrimination between LGD and HGD, the clinical hallmarks in 
Barrett‟s carcinogenesis, will possibly be the key metric for defining the true clinical 
value of fiberoptic confocal Raman spectroscopy. Because dysplastic foci are prone to 
biopsy sampling errors, fiberoptic confocal Raman spectroscopy could be used to 
accurately pinpoint these high-risk tissue areas in vivo in real-time as well as examine 
those lesions that are indefinite for dysplasia or presenting with extensive 
inflammation where histopathologic manifestations are insufficient for clinical 
decision making. It may even be possible to detect field carcinogenesis or prognostic 
information in patients occurring before histopathologic manifestations. Fiberoptic 
confocal Raman spectroscopy could therefore be used to objectively stratify those 
patients who have higher risk of developing EAC and prompt increased frequency of 
surveillance or therapeutic intervention for the individual patients. These facets of 
confocal Raman technology certainly warrant further investigations. Preemptive 
approaches or interventional procedures for HGD or intramucosal cancers are other 
scenarios where fiberoptic confocal Raman spectroscopy could have a potential key 
role to play. Confocal Raman endoscopy offers the gastroenterologist a novel 
objective tool, which allows real-time assessment of tissue pathology in situ, and 
therefore could be used to accurately define theresection margins of macroscopically 
inconspicuous dysplasia or cancers in BE patients undergoing surgical intervention 
(eg, endoscopic mucosal resection, endoscopic submucosal dissection, ablation). This 
could enable complete excision and subsequent margin assessment, so that malignant 
progression can be efficiently prevented. Today, the necessity for histopathologic 
characterization of biopsy specimens hinders diagnosis and therapeutic intervention 
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during the same endoscopic procedure. Confocal Raman technology opens up the 
possibility for combining final diagnosis and therapeutic eradication (eg, endoscopic 
mucosal resection, endoscopic submucosal dissection) in a single procedure, thereby 





We have demonstrated in this chapter that real-time fiber-optic confocal Raman 
spectroscopy can be performed prospectively in screening of the patients with 
suspicious BE in vivo. Fiber-optic confocal Raman spectroscopy uncovers the 
functional and biomolecular changes occurring in the epithelium during Barrett‟s 
carcinogenesis. Capitalizing on the rich epithelial Raman signatures acquired, fiber-
optic confocal Raman spectroscopy can be used to objectively target dysplasia in BE, 
illustrating its utility for improving in vivo precancer diagnosis and tissue 
characterization of BE at the molecular level during gastrointestinal endoscopy. 
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Chapter 8. Development of a multiplexed fingerprint and 
high wavenumber Raman spectroscopy technique for real-
time in vivo tissue Raman measurements at endoscopy 
In this chapter, we develop a multiplexed Raman spectroscopy technique using a 
single laser light together with a volume phase holographic (VPH) grating that 
simultaneously acquires both FP and HW tissue Raman spectra at endoscopy. We 
utilize a customized VPH dual-transmission grating, which disperses the incident 
Raman scattered light vertically onto two separate segments (i.e., 150 to 1950 cm
-1
; 
1750 to 3600 cm
-1
) of a CCD camera. We demonstrate that the multiplexed Raman 
technique can acquire high quality in vivo tissue Raman spectra ranging from 800 to 
3600 cm
-1
 within 1.0 s with a spectral resolution of ~3 to 6 cm
-1
 during clinical 
endoscopy. The rapid multiplexed Raman spectroscopy technique covering both FP 
and HW ranges developed in this work has potential for improving in vivo tissue 
diagnosis and characterization at endoscopy 
 
8.1 Introduction 
To date, most NIR Raman studies have been centered on the FP range (i.e., 800 
to 1800 cm
-1
) owing to the wealth of specific biomolecular information (i.e., protein, 
deoxyribonucleic acid, and lipid content) contained in this spectral region for tissue 
characterization and diagnosis.
54, 64, 89 With the commonly used NIR 785 nm laser 
excitation source, however, intense tissue autofluorescence background and fused 
silica Raman signal arising from fiber-optic Raman probes also fall into the FP range. 
The tissue autofluorescence can severely interfere with the detection of the inherently 
weak FP Raman signals by saturating the CCD. This remains the primary concern in 
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certain organs such as lung, liver, and stomach.
72, 91 Recent reports have shown that 
HW (i.e., 2800 to 3700 cm
-1
) Raman spectroscopy also contains valuable 
biomolecular information that can advantageously be used for diagnostic purposes.
114-
117, 127, 153
 The use of HW Raman spectroscopy is appealing due to the relatively 
intense tissue Raman signals generated (CH2 and CH3 moiety stretching vibrations of 
protein and lipids, OH stretching vibrations of water), as well as the considerably 
reduced fused silica fiber interferences and tissue autofluorescence that may allow a 
better assessment of the genuine tissue Raman signals.
114, 115
 A recent study has 
established that the integrated FP and HW Raman technique offers complementary 
diagnostic information for increasing the accuracy and robustness of detecting 
precancer in cervical tissue.
116
 To date, only very limited clinical work has been 
reported on the tissue Raman measurements covering both the FP and HW regions. 
The tissue Raman signals are measured either by successively switching the different 
laser excitation frequencies or by rotating the gratings for each spectral region,
153
 
which are not suitable for rapid in vivo measurements in clinical endoscopic settings. 
In this chapter, we report on the development of a novel multiplexed Raman 
spectroscopic technique that can simultaneously acquire both FP and HW in vivo 
tissue Raman spectra with high spectral resolution during endoscopy. 
 
8.2  Raman instrumentation 
Figure 8.1 shows the schematic of the multiplexed Raman spectroscopy system 
developed for simultaneous acquisition of the FP and HW Raman spectra in real-time 
under endoscopic image-guidance (i.e., WLR, NBI and AFI). The multiplexed Raman 
spectroscopy technique consists of a spectrum stabilized 785 nm diode laser 
(maximum output: 300 mW, B&W TEK Inc., Newark, Delaware), a transmissive 
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imaging spectrograph (Holospec f/1.8, Kaiser Optical Systems Inc., Ann Arbor, 
Michigan) equipped with a liquid nitrogen-cooled (-120°C), NIR-optimized, back-
illuminated and deep depletion CCD camera (1340  400 pixels at 20  20 m per 
pixel; Spec-10: 400BR/LN, Princeton Instruments, Roper Scientific Inc., Trenton, 
New Jersey). We integrate a VPH dual-transmission grating consisting of two hybrid 
VPH gratings (1400 and 1600 g/mm) (HoloPlex, Kaiser Optical Systems Inc., Ann 
Arbor, Michigan) into the spectrograph for Raman spectral dispersion.
154
 The hybrid 
gratings are cemented closely together with a tilted angle of 0.2- degree to achieve a 
separation between the low frequency and high frequency spectral components. The 
Bragg wavelengths of the hybrid gratings are tuned to two different spectral ranges 
(i.e., ~150 to 1950 cm
-1
 and 1750 to 3600 cm
-1
) such that it disperses the tissue 
Raman spectra (i.e., FP and HW spectra) onto two separate vertical segments of the 
CCD, accordingly.  
 
Figure 8.1 Schematic diagram of the rapid multiplexed Raman spectroscopy technique for 
simultaneous acquisition of both the fingerprint (FP) and high wavenumber (HW) Raman spectra 
under trimodal endoscopic imaging (i.e., white light reflectance (WLR), narrowband imaging 
(NBI), autofluorescence imaging (AFI)) guidance. A customized dual-transmission VPH grating is 
incorporated into the Raman system for dispersion of FP and HW Raman spectra onto different 
vertical segments of a CCD. 
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This multiplexed Raman spectroscopy technique based on a VPH dual-transmission 
grating permits simultaneous coverage of both the FP and HW spectral segments 
while maintaining a high spectral resolution of a single high-density grating. To 
correct for the image aberration in the transmissive spectrograph, a customized 
parabolic aligned fiber bundle (26 × 100 µm fibers, NA = 0.22) was coupled into the 
entrance slit of the spectrograph for significantly improving the signal-to-noise ratio 
(SNR) as well as the spectral resolution of the multiplexed Raman system as 
compared to a conventional straight slit imaging spectrograph.
54
 This allows us to 
completely hardware bin the two separate CCD segments vertically for improving the 
SNR (of up to 14(=200
1/2
) and spectral resolution (3 - 6 cm
-1
) of the Raman spectra.
54 
This is adequate for tissue spectroscopy that contains broad overlapping peaks. The 
two spectral segments are simultaneously readout so that the FP and HW regions can 
be spliced into a complete high-resolution broadband Raman spectrum covering ~150 
to 3600 cm
-1
. The rapid multiplexed Raman spectroscopy technique developed for 
endoscopy was wavelength calibrated to an accuracy (~2 cm
-1
) using an 
argon/mercury spectral lamp (AR-1 and HG-1, Ocean Optics Inc., Dunedin, Florida) 
and the Raman spectrum of 4-acetamidophenol that exhibits strong well-defined 
peaks in the HW region at 2931 cm
-1 and 3064 cm
-1 (ASTM E1840 standard). To 
correct for the spectral response of the system, intensity calibration was performed 
using a standard tungsten lamp (RS-10, EG&G Gamma Scientific, San Diego, 
California) of the two distinct CCD segments separately. In this work, the 1.8 mm 
fiber-optic confocal Raman probe coupled with a 1.0 mm sapphire ball lens was used 
for epithelial tissue Raman measurements during endoscopic procedures. We have 
also developed customized software to process the two distinct CCD segments in real-
time during clinical endoscopy, and the proper probe-tissue contact handling can be 
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verified on-line using outlier detection algorithms. 
8.3 Data processing 
The real-time data processing specially developed for this biomedical 
multiplexed FP and HW Raman spectroscopy technique includes silica fiber 
background subtraction, intensity and wavelength calibration, cosmic rays and signal 
saturation detection/rejection, autofluorescence background subtraction and linear 
Savitzky-Golay smoothing (5 pixel window).
43
 Different tissue autofluorescence 
background subtraction schemes were employed for robust extraction of the tissue 




 order polynomial 
constrained to the lower portion of the FP Raman spectra is used and this polynomial 
is then subtracted from the measured spectrum to resolve the FP tissue Raman signal. 
In the HW region (i.e., 2800 to 3600 cm
-1
), we found that 1
st
 order polynomials 
constrained to the lower portion of the HW Raman spectra are optimal for extracting 
the Raman spectra. All Raman spectra are also normalized to the integrated areas 
under the FP and HW Raman spectral regions, respectively, to reduce power density 




8.4 Results and discussion 
Figure 8.2 shows the full frame CCD image of a parabolic-configured fiber 
bundle illuminated with argon/mercury spectral lamps (AR-1 and HG-1, Ocean 
Optics Inc., Dunedin, Florida). With this specific fiber arrangement, the atomic 
emission lines are substantially straight, indicating effective image-aberration 
correction on the segmented CCD.
54
 This in turn allows us to hardware bin the two 
well-defined CCD regions covering 1340 × 200 pixels without compromising spectral 
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resolutions or reducing the SNR ratio. The lower segment of the CCD array covers 
the FP region (i.e., ~150 to 1950 cm
-1
), and we obtained a spectral resolution of ~6 
cm
-1
 over the entire FP range using the 100 µm core diameter fibers. On the other 
hand, the upper segment of the CCD array covers the spectral range of 1750 to 3600 
cm
-1
 comprising the nonspecific Raman region (~1800 to 2800 cm
-1
) and the HW 
spectral region (i.e., 2800 to 3600 cm
-1
) with a spectral resolution of ~3 cm
-1
. Since 
the dispersion is holographically encoded in the grating for both FP and HW spectral 
regions, the signal magnitude and resolution of a single high-density grating are 
essentially maintained. 
 
Figure 8.2 Image of a parabolic arranged fiber bundle (26 × 100 µm, NA = 0.22) illuminated 
with an argon/mercury lamp, illustrating the fully correction of image-aberration in spectrograph. 
The customized dual-transmission VPH grating efficiently disperses the FP and HW Raman 
spectra onto different vertical CCD segments. The lower segment covers the FP region ~150 to 
1950 cm
-1 (spectral resolution of 6 cm
-1
) while the upper segment covers the nonspecific Raman 
range and the HW range from 1750 to 3600 cm
-1




We have illustrated the utility of the rapid multiplexed Raman spectroscopy system 
for real-time in vivo Raman measurements of epithelial tissue under wide-field 
endoscopic imaging (i.e., WLR/NBI/AFI) guidance. Figure 8.3 shows an example of 
in vivo Raman spectra acquired from different anatomical sites in the head and neck 
(i.e., attached gingiva, buccal mucosa, dorsal tongue, hard palate, and oropharynx) 
from a healthy volunteer under endoscopic imaging guidance. The FP and HW in vivo 
tissue Raman spectra can be acquired simultaneously with an integration time of 0.5 s 
and presented on the Raman endoscopy monitor in real-time. Highly resolved tissue 
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Raman peaks in the head and neck are observed in the FP range with tentative 
molecular assignments as follows: 853 cm
-1 (υ(C-C) of proteins), 956 cm-1 (υs(P=O) 
of hydroxyapatite), 1004 cm
-1
 (υs(C-C) ring breathing of phenylalanine), 1078 cm
-1
 
(υ(C-C)of lipids), 1265 cm-1 (amide III υ(C-N) and δ(N-H) of proteins), 1302 cm-1 
(CH3CH2 twisting and wagging of proteins), 1445 cm
-1
 δ(CH2) deformation of 
proteins and lipids), 1655 cm
-1 (amide I υ(C=O) of proteins), and 1745 cm-1 υ(C=O) 
of lipids. Intense Raman peaks are also seen in the HW region such as 2850 and 2885 
cm
-1 (symmetric and asymmetric CH2 stretching of lipids), 2940 cm
-1 (CH2 stretching 
of proteins) as well as the broad Raman band of water (OH stretching vibrations that 
peak at 3400 cm
-1
 in the 3100 to 3600 cm
-1
 region) (Table 1).  
 
Figure 8.3 Example of in vivo Raman spectra acquired from different tissue sites (i.e., attached 
gingiva, buccal mucosa, dorsal tongue, hard palate and oropharynx) in the oral cavity from a 
healthy volunteer using the multiplexed Raman spectroscopy technique under endoscopic imaging 
guidance. The spectra are shifted vertically and normalized to the integrated areas in the FP and 
HW regions, respectively, for better comparisons of line shapes. All Raman spectra are acquired 
using an integration time of 0.5 s under the 785 nm illumination power of 1.5  W/cm2. In vivo 
fiber-optic Raman endoscopic acquisitions under WLR imaging guidance are also shown. 
 
 
The approximate SNR of 25 could be obtained from in vivo tissue using 1.0 s 
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integration time when the fiber-optic confocal Raman probe is in gentle contact with 
the buccal mucosa. Although the Raman band of water observed was relatively noisy 
due to the low quantum efficiency above 1090 nm of the CCD camera used, it may 
still contain important diagnostic information related to the local conformation and 
interactions of hydrogen-bonds in the cellular and extracellular space of tissue.
155 The 
OH stretching vibrations have been found to be associated with aquaporins and 
protein/water interactions in precancer and cancer tissues.
155
 Therefore, compared 
with either FP or HW Raman spectroscopy technique alone, the multiplexed Raman 
spectroscopy technique utilizing a single excitation laser source together with a VPH 
dual-transmission grating provides both the FP and HW Raman spectra 
simultaneously (including OH stretching vibrations of water) with high spectral 
resolution (i.e., 3 to 6 cm
-1






In summary, we report in this chapter on the development of a novel 
multiplexed Raman spectroscopy technique for simultaneous acquisition of the FP 
(800 to 1800 cm
-1
) and HW (2800 to 3600 cm
-1
) tissue Raman spectra in vivo with 
high spectral resolution (3 to 6 cm
-1
). We demonstrate that high quality in vivo Raman 
spectra ranging from 800 to 3600 cm
-1
 of different tissue sites in the head and neck 
can be measured within 1.0 s integration time during endoscopic examination. The 
rapid multiplexed Raman spectroscopy technique with high spectral resolution 
developed in this work opens the opportunity for improving real-time in vivo tissue 
Raman diagnosis and characterization at endoscopy. 
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Chapter 9. Conclusions and future directions 
We have herein advanced the field of biomedical Raman spectroscopy through 
a translational clinical study with the endpoint of applying fiber-optic Raman 
spectroscopy prospectively for in vivo endoscopic precancer and cancer diagnostics. 
In Chapter 4 we developed a novel fiber-optic endoscopic Raman spectroscopy 
technique using a customized fiber-optic Raman probe. This novel clinical instrument 
enabled tissue Raman spectra to be acquired within 0.5 sec which is necessary to meet 
the clinical requirements of rapid data acquisition. This is a factor of ~10 faster than 
any previously reported Raman techniques in the GI tract.
118
 We demonstrated that 
this permits clinicians to nondestructively assess the endogenous biochemical and 
morphological information of GI tissues under the wide-field endoscopic imaging 
(WLR, NBI, and AFI) guidance. In Chapter 5 we elucidated the most prominent 
pathological features of intestinal-type gastric cancer and demonstrated the diagnostic 
capability of Raman spectroscopy for detecting precancers and cancers in vivo. To be 
able to apply fiber-optic Raman spectroscopy prospectively in clinical diagnostics it is 
necessary to apply sophisticated multivariate/chemometric analysis in real-time. 
Hence, we developed a novel on-line framework which enables real-time 
multivariate/chemometric analysis within 0.13 s. This is the first real-time Raman 
endoscopic technique that permits prospective and probabilistic tissue analysis based 
on a comprehensive patient database stored in the instrument itself. To improve the 
sensitivity for detecting epithelial lesions we also developed at depth-resolving fiber-
optic Raman probe with confocal properties to selectively interrogate superficial 
tissues. This confocal-type Raman probe was tested in 77 esophagus patients, which 
represents the first prospective study reported to date in the literature and is therefore 
a milestone in clinical applications of Raman endoscopy. To further advance the field 
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we also developed a multiplexed FP and HW Raman endoscopy platform with 
improved resolution, broadband capability and real-time capability. This multiplexed 
Raman endoscope technique has potential to improve tissue characterization and 
diagnosis since complementary biomolecular information can be acquired from 
different spectral ranges in high resolution. 
 
 The use of fiber-optic Raman spectroscopy may include many clinical 
scenarios that require histopathologic biopsy samplings in screening of patients at 
higher risk of developing cancer. Ultimately, the targeting of dysplastic lesions and 
the discrimination between LGD and HGD, the clinical hallmarks in most GI 
carcinogenesis, will possibly be the key metric for defining the true clinical value of 
fiber-optic confocal Raman spectroscopy. Because dysplastic foci are prone to biopsy 
sampling errors, fiber-optic confocal Raman spectroscopy could be used to accurately 
pinpoint these high-risk tissue areas in vivo in real-time as well as examine those 
lesions that are indefinite for dysplasia or presenting with extensive inflammation 
where histopathologic manifestations are insufficient for clinical decision making. It 
may even be possible to detect field carcinogenesis or prognostic information in 
patients occurring before histopathologic manifestations. Fiber-optic confocal Raman 
spectroscopy could therefore be used to objectively stratify those patients who have 
higher risk of developing cancer and prompt increased frequency of surveillance or 
therapeutic intervention for the individual patients. These facets of Raman technology 
certainly warrant further investigations. Preemptive approaches or interventional 
procedures for HGD or intramucosal cancers are other scenarios where fiber-optic 
Raman spectroscopy could have a potential key role to play. Confocal Raman 
endoscopy offers the gastroenterologist a novel objective tool, which allows real-time 
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assessment of tissue pathology in situ, and therefore could be used to accurately 
define the resection margins of macroscopically inconspicuous dysplasia or cancers in 
patients undergoing surgical intervention (e.g., endoscopic mucosal resection, 
endoscopic submucosal dissection, ablation). This could enable complete excision and 
subsequent margin assessment, so that malignant progression can be efficiently 
prevented. Today, the necessity for histopathologic characterization of biopsy 
specimens hinders diagnosis and therapeutic intervention during the same endoscopic 
procedure. Confocal Raman technology opens up the possibility for combining final 
diagnosis and therapeutic eradication (e.g., endoscopic mucosal resection, endoscopic 
submucosal dissection) in a single procedure, thereby effectively reducing medical 
cost and burden associated with multiple endoscopic procedures. Fiber-optic confocal 
Raman spectroscopy also provides uninterrupted real-time diagnosis, which is 
straightforward to operate and requires no additional endoscopic training or 
administration of contrast agents. In our hospital, the confocal Raman technique is 
now routinely used by both experienced and novice clinicians to gather Raman 
spectral data without any difficulty. These clinical advantages will undoubtedly make 
Raman technique a competitive new modality with potential for rapid adoption and 
translation into gastroenterology. Because the basic principle of Raman spectroscopy 
is fundamentally different from endoscopic imaging modalities (e.g., WLR, NBI, 
AFI), Raman spectroscopy could possibly be complementary to conventional 
endoscopy. Fiber-optic Raman spectroscopy brings endoscopic examinations much 
closer to a molecular foundation and could challenge the current resource-intensive 
biopsy protocols. The endoscopist can now apply Raman endoscope to analyze the 
biomolecular signature of cells and tissues in vivo, thereby enabling noninvasive 
optical biopsies of suspicious lesions during ongoing endoscopy. The results of this 
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dissertation therefore illustrate the great potential of Raman endoscope technology for 
non-invasive, in vivo diagnosis and detection of pre-cancer and early cancer in the 
gastrointestinal system. We envisage that within the next five years, the fiber-optic 
Raman spectroscopy technique will be emerging as a new routine endoscopic tool for 
shaping in vivo biomedical diagnosis in hospitals. 
 
9.1 Conclusions 
Below we summarize the key achievements presented in this dissertation. 
 
 A novel fiber-optic Raman spectroscopy technique was developed which enables 
acquisition of tissue Raman spectra in real-time from the upper GI tract. High-
quality in vivo Raman spectra can be acquired from different sites of the upper GI 
(i.e., gastric and esophagus) in real-time during clinical endoscopic examinations. 
We applied the fiber-optic Raman technique for in vivo tissue characterization.  
The NNLSM coupled with a reference database of Raman active biochemicals 
(i.e., actin, histones, collagen, DNA, and triolein) was employed for semi-
quantitative biomolecular modeling of tissue constituents in the upper GI. A total 
of 1189 in vivo Raman spectra were analyzed from different locations in the 
upper GI. The Raman spectra among the distal, middle, and proximal sites of the 
esophagus showed no significant interanatomical variability. The interanatomical 
variability of Raman spectra among normal gastric tissue (antrum, body, and 
cardia) was subtle compared to cancerous tissue transformation, whereas 
biomolecular modeling revealed significant differences between the two organs, 
particularly in the GE junction.  
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 To validate the potential of Raman endoscopy we assessed the capability for 
multi-class elucidation of intestinal-type gastric carcinogenesis sequence in vivo 
at endoscopy. We analyze 1277 in vivo Raman spectra from 83 gastric patients 
associated with intestinal-type carcinogenesis. The results show that in vivo 
Raman spectroscopy integrated with semi-quantitative spectral modeling (e.g., 
DNA, lipids, glycoprotein, proteins and blood) reveals the progressive changes of 
biochemical constituents in gastric tissue associated with preneoplastic and 
neoplastic transformation (i.e., IM, dysplasia and adenocarcinoma). Multi-class 
probabilistic partial least squares-discriminant analysis (PLS-DA) diagnostic 
algorithms based on in vivo Raman spectra are able to identify normal mucosa 
with sensitivity of 75.88% and specificity of 87.21%; IM with sensitivity of 
46.67% and specificity of 87.55%; dysplasia with sensitivity of 83.33%; 
specificity of 95.80%, and adenocarcinoma with sensitivity of 84.91% and 
specificity 95.57%, respectively. 
 Since data analysis of GI tissue Raman spectra has been limited to post-
processing and off-line diagnostic algorithms we developed a novel on-line 
diagnostic framework that implements acquisition, preprocessing, outlier 
detection based on principal component analysis statistics (i.e., Hotelling‟s T2 
and Q-residuals) for tissue Raman spectra verification as well as probabilistic 
multivariate diagnostics. Free-running optical diagnosis and processing time of < 
0.13 s can be achieved, which is a key achievement towards realizing real-time in 
vivo prospective tissue diagnostics during clinical endoscopic examination. We 
also demonstrated prospective cancer diagnosis in the gastric for the first time.  
 To improve the sensitivity to precancer we developed a fiber-optic confocal-type 
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Raman technique. We demonstrated that real-time fiber-optic confocal Raman 
spectroscopy technique developed can be used prospectively in surveillance and 
screening of the patients with Barrett‟s esophagus in vivo. Confocal Raman 
spectra showed significant spectral differences (p < 0.001) among different 
esophageal tissue types (i.e., columnar-lined epithelium, nondysplastic  
BE and dysplastic BE). Fiber-optic confocal Raman spectroscopy provides a 
diagnostic sensitivity of 87.0% (67/77) and a specificity of 84.7% (610/720) for 
in vivo detection of dysplasia in 77 patients prospectively based on endogenous 
biomolecular signatures.  
 To further advance the research, we developed a second generation multiplexed 
Raman spectroscopy technique for simultaneous acquisition of the FP (800 to 
1800 cm
-1
) and HW (2800 to 3600 cm
-1
) tissue Raman spectra in vivo with high 
spectral resolution (3 to 6 cm
-1
). We demonstrate that high quality in vivo Raman 
spectra ranging from 800 to 3600 cm
-1
 of different tissue sites in the head and 
neck can be measured within 1.0 s integration time during endoscopic 
examination. The rapid multiplexed Raman spectroscopy technique with high 
spectral resolution developed in this work opens the opportunity for improving 







9.2 Future directions 
The work presented in the thesis mainly focused on the development and 
validation of fiber-optic Raman spectroscopy technique for endoscopic tissue 
diagnosis. There are methodological limitations in the current study as follows: (i) 
Biopsy was considered as gold standard. This implies that the co-targeting of the 
Raman measurement and biopsy sampling must be accurate in order to obtain an 
unbiased estimate of performance. Errors in the reported accuracies could be related 
to erroneous sampling which is an intrinsic uncertainty in this type of study. This 
effect could be quantitatively assessed through a multi-operator study using 
experienced and novice endoscopists. Secondly, although we used expert 
gastrointestinal pathologists it is well know that histopathological characterization of 
minute specimens can be highly subjective.
23
 For instance, inter-observer 
disagreements of up to >50% have been reported for LGD in BE.
23
 Hence, the 
diagnostic accuracy of Raman spectroscopy could be further improved using 
consensus pathology of several pathologists. (ii) Our dataset is limited in the number 
of patients with precancer (i.e., LGD and HGD) and cancer. This could give a 
misbalance in the accuracy reported. Also, we have not yet proved that Raman 
endoscopy is able to identify macroscopically invisible areas of dysplasia. (iii) 
Another limitation is that in vivo Raman spectra were acquired from a biased 
population of high-risk patients. (iv) Prospective diagnostics in our study was 
performed in a testing scenario. It is important to mention that the current Raman 
technology could aid endoscopists but might however not replace histopathology 
since Raman endoscopy provides little spatial information (e.g., invasion depth etc.). 
In order to assess the true clinical merit it is necessary to evaluate if Raman 
endoscopy can improve the guidance and yield of biopsies. Given the current stage of 
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this research, there are still issues to be addressed in order for the technology to gain 
clinical acceptance as a routine tool. This also includes standardization and 
conduction of multicenter randomized clinical trials. Some directions for further 
research are proposed as follows: 
 
 Firstly, when using Raman spectroscopy to analyze tissue, the excitation laser 
power must be kept low to prevent thermal damage to tissue. Hence, light 
dosimetry for maximum permissible laser irradiation in internal organs is highly 
required, which is currently falling far behind the pace of Raman technology 
advancement. This is important with respect to health, safety and regulatory 
authorities. Standards need to be set for the exposure limits of NIR light to 
internal organs.  
 
 Robust multivariate/chemometric approaches together with layered tissue 
modeling related to tissue optical properties (scattering and absorption 
coefficients, anisotropy) must also be developed for extracting biochemical and 
morphological diagnostic information in biomedical Raman spectroscopy for 
accurate tissue diagnosis and classification. Moreover, to better understand the 
spectral characteristics of in vivo Raman spectra and associated GI carcinogenesis, 
it would be informative to spectrally map histopathological tissue slides using 
confocal Raman microspectroscopy. Multivariate statistical analysis could then be 
employed i.e., PCA, biomolecular modelling, clustering and/or spectral unmixing 
methods etc. to extract biochemical and morphological information from GI 
mucosa. This could aid in better understanding of the distribution of Raman 
scatters in the gastric and esophagus for further improving diagnostic algorithm 
development and fiber-optic probe designs. 
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 Fiber-optic Raman spectroscopy has also mainly been limited to single system 
configurations and no attempts have been made to transfer into multi-centre 
clinical trials. Because Raman spectroscopy relies on extremely weak, well-
resolved signals and the technique is very sensitive to instrumental changes such 
as interchanging of fiber-optic probes, this could limit the practical use in clinical 
trials and routine diagnostics. Instrument standardization therefore remains a very 
important subject for investigation in the future. Instrumental standardization also 
includes the assessment of probe durability, manufacturing and approval from 
regulatory authorities. 
 
 One needs to validate the effect of confounding factors including probe pressure, 
temperature, ambient light conditions etc. It is however our practical experience 
that these are negligible compared to the tissue variance itself, but this needs to be 
scientifically proven. In addition the effects of age, gender, ethnicity must be 
evaluated for the technique to become a routine tool on hospitals in different parts 
of the world. 
 
 Further, combining real-time fiber-optic Raman spectroscopy with other optical 
imaging techniques (e.g. hyper-spectral imaging, diffuse optical tomography 
(DOT), optical coherence tomography (OCT), confocal endomicroscopy imaging, 
and multiphoton imaging) and/or conventional biomedical imaging (e.g. ultra-
sound, computed tomography (CT), and magnetic resonance imaging (MRI)) may 
also be the direction to explore for functional imaging at the molecular, cellular, 
tissue and even organ levels. The integration with OCT or confocal 
endomicroscopy could be particularly interesting directions to explore. OCT 
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provides micro-structural imaging with morphological information. The co-
registration of Raman spectroscopy and OCT
156, 157
 or confocal endomicroscopy 
could potentially enhance the tissue characterization and in vivo diagnosis. Future 
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